Skip to main content
Download PDF

Hygienemaßnahmen zur Prävention der Infektion durch Enterokokken mit speziellen Antibiotikaresistenzen

Empfehlung der Kommission für Krankenhaushygiene und Infektionsprävention (KRINKO) beim Robert Koch-Institut

    Bundesgesundheitsblatt - Gesundheitsforschung - Gesundheitsschutz volume 61, pages 1310–1361 (2018)Cite this article

    Literatur

    1. DiazGranados CA, Zimmer SM, Mitchel K, Jernigan JA (2005) Comparison of mortality associated with vancomycin-resistant and vancomycin-susceptible enterococcal bloodstream infections: a meta-analysis. Clin Infect Dis 41(3):327–333

      Article  PubMed  Google Scholar 

    2. Spera RV Jr., Farber BF (1992) Multiply-resistant Enterococcus faecium. The nosocomial pathogen of the 1990s. JAMA 268(18):2563–2564

      Article  PubMed  Google Scholar 

    3. Acar J, Casewell M, Freeman J, Friis C, Goossens H (2000) Avoparcin and virginiamycin as animal growth promoters: a plea for science in decision-making. Clin Microbiol Infect 6(9):477–482

      Article  CAS  PubMed  Google Scholar 

    4. Marshall BM, Levy SB (2011) Food animals and antimicrobials: impacts on human health. Clin Microbiol Rev 24(4):718–733

      Article  CAS  PubMed  PubMed Central  Google Scholar 

    5. Remschmidt C, Schröder C, Behnke M, Gastmeier P, Geffers C, Kramer TS (2018) Continuous increase of vancomycin resistance in enterococci causing nosocomial infections in Germany− 10 years of surveillance. Antimicrob Resist Infect Control 7(1):54

      Article  PubMed  PubMed Central  Google Scholar 

    6. Bundesamt für Verbraucherschutz und Lebensmittelsicherheit (BVL), Paul-Ehrlich-Gesellschaft für Chemotherapie e.V. (PEG) (2016) GERMAP 2015. Bericht über den Antibiotikaverbrauch und die Verbreitung von Antibiotikaresistenzen in der Human- und Veterinärmedizin in Deutschland. Antiinfectives Intelligence: Rheinbach. http://www.p-e-g.org/econtext/germap . Zugegriffen: 22. März 2018

      Google Scholar 

    7. World Health Organization (WHO) (2017) Global priority list of antibiotic-resistant bacteria to guide research, discovery, and development of new antibiotics. http://www.who.int/entity/medicines/publications/WHO-PPL-Short_Summary_25Feb-ET_NM_WHO.pdf . Zugegriffen: 22. März 2018

      Google Scholar 

    8. von Baum H, Dettenkofer M, Fahr AM, Heeg P, Wendt C (2006) Umgang mit Patienten mit Glykopeptid-resistenten Enterokokken (GRE)/Vancomycin-resistenten Enterokokken (VRE). Hyg Med 31(1):30–32

      Google Scholar 

    9. Huskins WC, Huckabee CM, O'grady NP et al (2011) Intervention to reduce transmission of resistant bacteria in intensive care. N Engl J Med 364(15):1407–1418

      Article  PubMed  PubMed Central  Google Scholar 

    10. Mutters NT, Mersch-Sundermann V, Mutters R, Brandt C, Schneider-Brachert W, Frank U (2013) Kontrolle von Vancomycin-resistenten Enterokokken im Krankenhaus. Epidemiologischer Hintergrund und klinische Relevanz. Dtsch Arztebl Int 110(43):725–731

      PubMed  PubMed Central  Google Scholar 

    11. Sprague E, Reynolds S, Brindley P (2016) Patient isolation precautions: are they worth it? Can Respir J. https://doi.org/10.1155/2016/5352625

      Article  PubMed  PubMed Central  Google Scholar 

    12. Kommission für Krankenhaushygiene und Infektionsprävention (KRINKO) (2005) Infektionsprävention in Heimen. Bundesgesundheitsblatt 48(9):1061–1080

      Article  Google Scholar 

    13. Kommission für Krankenhaushygiene und Infektionsprävention (KRINKO) (2002) Ausbruchmanagement und strukturiertes Vorgehen bei gehäuftem Auftreten nosokomialer Infektionen. Bundesgesundheitsblatt 45(2):180–186

      Article  Google Scholar 

    14. Kommission für Krankenhaushygiene und Infektionsprävention (KRINKO) (2015) Infektionsprävention im Rahmen der Pflege und Behandlung von Patienten mit übertragbaren Krankheiten. Empfehlung der Kommission für Krankenhaushygiene und Infektionsprävention (KRINKO) beim Robert Koch-Institut. Bundesgesundheitsblatt 58(10):1151–1170

      Article  Google Scholar 

    15. Kommission für Krankenhaushygiene und Infektionsprävention (KRINKO) (2016) Händehygiene in Einrichtungen des Gesundheitswesens. Bundesgesundheitsblatt 59(9):1189–1220

      Article  Google Scholar 

    16. Kommission für Krankenhaushygiene und Infektionsprävention (KRINKO) (2004) Empfehlung zu den Anforderungen an die Hygiene bei der Reinigung und Desinfektion von Flächen. Bundesgesundheitsblatt 4(7):51–61

      Google Scholar 

    17. Kommission für Krankenhaushygiene und Infektionsprävention (KRINKO) (2010) Anforderungen an die Hygiene bei der medizinischen Versorgung von immunsupprimierten Patienten. Bundesgesundheitsblatt 53(4):357–388

      Article  Google Scholar 

    18. Kommission für Krankenhaushygiene und Infektionsprävention (KRINKO) (2007) Empfehlung zur Prävention nosokomialer Infektionen bei neonatologischen Intensivpflegepatienten mit einem Geburtsgewicht unter 1500 g. Bundesgesundheitsblatt 50(10):1265–1303

      Article  Google Scholar 

    19. Kommission für Krankenhaushygiene und Infektionsprävention (KRINKO) (2010) Die Kategorien in der Richtlinie für Krankenhaushygiene und Infektionsprävention - Aktualisierung der Definitionen. Mitteilung der Kommission für Krankenhaushygiene und Infektionsprävention. Bundesgesundheitsblatt 53(7):754–756

      Article  Google Scholar 

    20. Magiorakos AP, Srinivasan A, Carey RB et al (2011) Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance. Clin Microbiol Infect 18(3):268–281

      Article  PubMed  Google Scholar 

    21. Teixeira LM, Carvalho MGS, Facklam RR, Shewmaker PL (2015) Enterococcus. In: Jorgensen HJ, Pfaller MA, Carrol KC et al (Hrsg) Manual of clinical microbiology, 11. Aufl. ASM Press, Washington, S 403–421

      Chapter  Google Scholar 

    22. Lytsy B, Engstrand L, Gustafsson A, Kaden R (2017) Time to review the gold standard for genotyping vancomycin-resistant enterococci in epidemiology: comparing whole-genome sequencing with PFGE and MLST in three suspected outbreaks in Sweden during 2013-2015. Infect Genet Evol 54:74–80

      Article  CAS  PubMed  Google Scholar 

    23. Robert Koch-Institut (RKI) (2013) Surveillance nosokomialer Infektionen sowie die Erfassung von Krankheitserregern mit speziellen Resistenzen und Multiresistenzen. Fortschreibung der Liste der gemäß § 4 Abs. 2 Nr. 2 Buchstabe b in Verbindung mit § 23 Abs. 4 IfSG zu erfassenden nosokomialen Infektionen und Krankheitserreger mit speziellen Resistenzen und Multiresistenzen. Bundesgesundheitsblatt (56):580-583

    24. Köhler W (2007) The present state of species within the genera Streptococcus and Enterococcus. Int J Med Microbiol 297(3):133–150

      Article  CAS  PubMed  Google Scholar 

    25. Tedim AP, Ruiz-Garbajosa P, Corander J et al (2015) Population biology of intestinal enterococcus isolates from hospitalized and nonhospitalized individuals in different age groups. Appl Environ Microbiol 81(5):1820–1831

      Article  CAS  PubMed  PubMed Central  Google Scholar 

    26. Noble CJ (1978) Carriage of group D streptococci in the human bowel. J Clin Pathol 31(12):1182–1186

      Article  CAS  PubMed  PubMed Central  Google Scholar 

    27. Fisher K, Phillips C (2009) The ecology, epidemiology and virulence of Enterococcus. Microbiology 155(Pt 6):1749–1757

      Article  CAS  PubMed  Google Scholar 

    28. McBride SM, Fischetti VA, Leblanc DJ, Moellering RC Jr., Gilmore MS (2007) Genetic diversity among Enterococcus faecalis. PLoS ONE 2(7):e582

      Article  CAS  PubMed  PubMed Central  Google Scholar 

    29. Kuch A, Willems RJ, Werner G et al (2012) Insight into antimicrobial susceptibility and population structure of contemporary human Enterococcus faecalis isolates from Europe. J Antimicrob Chemother 67(3):551–558

      Article  CAS  PubMed  Google Scholar 

    30. Zischka M, Kunne CT, Blom J et al (2015) Comprehensive molecular, genomic and phenotypic analysis of a major clone of Enterococcus faecalis MLST. BMC Genomics 16(175):T40

      Google Scholar 

    31. Leavis H, Top J, Shankar N et al (2004) A novel putative enterococcal pathogenicity island linked to the esp virulence gene of Enterococcus faecium and associated with epidemicity. J Bacteriol 186(3):672–682

      Article  CAS  PubMed  PubMed Central  Google Scholar 

    32. Werner G, Fleige C, Geringer U, van Schaik W, Klare I, Witte W (2011) IS element IS16 as a molecular screening tool to identify hospital-associated strains of Enterococcus faecium. BMC Infect Dis 11:80

      Article  PubMed  PubMed Central  Google Scholar 

    33. Heikens E, van Schaik W, Leavis HL, Bonten MJ, Willems RJ (2008) Identification of a novel genomic island specific to hospital-acquired clonal complex 17 Enterococcus faecium isolates. Appl Environ Microbiol 74(22):7094–7097

      Article  CAS  PubMed  PubMed Central  Google Scholar 

    34. Top J, Willems R, Blok H et al (2007) Ecological replacement of Enterococcus faecalis by multiresistant clonal complex 17 Enterococcus faecium. Clin Microbiol Infect 13(3):316–319

      Article  CAS  PubMed  Google Scholar 

    35. Lester CH, Sandvang D, Olsen SS et al (2008) Emergence of ampicillin-resistant Enterococcus faecium in Danish hospitals. J Antimicrob Chemother 62(6):1203–1206

      Article  CAS  PubMed  Google Scholar 

    36. Lebreton F, van Schaik W, McGuire AM et al (2013) Emergence of epidemic multidrug-resistant Enterococcus faecium from animal and commensal strains. MBio 4(4):e00534-13

      Article  CAS  PubMed  PubMed Central  Google Scholar 

    37. McCracken M, Wong A, Mitchell R et al (2013) Molecular epidemiology of vancomycin-resistant enterococcal bacteraemia: results from the Canadian Nosocomial Infection Surveillance Program, 1999-2009. J Antimicrob Chemother 68(7):1505–1509

      Article  CAS  PubMed  Google Scholar 

    38. Raven KE, Reuter S, Reynolds R et al (2016) A decade of genomic history for healthcare-associated Enterococcus faecium in the United Kingdom and Ireland. Genome Res 26(10):1388–1396

      Article  CAS  PubMed  PubMed Central  Google Scholar 

    39. McAuley CM, Gobius KS, Britz ML, Craven HM (2012) Heat resistance of thermoduric enterococci isolated from milk. Int J Food Microbiol 154(3):162–168

      Article  CAS  PubMed  Google Scholar 

    40. Renner P, Peters J (1999) Resistance of enterococci to heat and chemical agents. Zentralbl Hyg Umweltmed 202(1):41–50

      Article  CAS  PubMed  Google Scholar 

    41. Kearns AM, Freeman R, Lightfoot NF (1995) Nosocomial enterococci: resistance to heat and sodium hypochlorite. J Hosp Infect 30(3):193–199

      Article  CAS  PubMed  Google Scholar 

    42. Martinez S, Lopez M, Bernardo A (2003) Thermal inactivation of Enterococcus faecium: effect of growth temperature and physiological state of microbial cells. Lett Appl Microbiol 37(6):475–481

      Article  CAS  PubMed  Google Scholar 

    43. Bale MJ, Bennett PM, Beringer JE, Hinton M (1993) The survival of bacteria exposed to desiccation on surfaces associated with farm buildings. J Appl Bacteriol 75(6):519–528

      Article  CAS  PubMed  Google Scholar 

    44. Noskin GA, Stosor V, Cooper I, Peterson LR (1995) Recovery of vancomycin-resistant enterococci on fingertips and environmental surfaces. Infect Control Hosp Epidemiol 16(10):577–581

      Article  CAS  PubMed  Google Scholar 

    45. Wendt C, Wiesenthal B, Dietz E, Ruden H (1998) Survival of vancomycin-resistant and vancomycin-susceptible enterococci on dry surfaces. J Clin Microbiol 36(12):3734–3736

      CAS  PubMed  PubMed Central  Google Scholar 

    46. Neely AN (2000) A survey of gram-negative bacteria survival on hospital fabrics and plastics. J Burn Care Rehabil 21(6):523–527

      Article  CAS  PubMed  Google Scholar 

    47. Neely AN, Maley MP (2000) Survival of enterococci and staphylococci on hospital fabrics and plastic. J Clin Microbiol 38(2):724–726

      CAS  PubMed  PubMed Central  Google Scholar 

    48. Robine E, Derangere D, Robin D (2000) Survival of a Pseudomonas fluorescens and Enterococcus faecalis aerosol on inert surfaces. Int J Food Microbiol 55(1-3):229–234

      Article  CAS  PubMed  Google Scholar 

    49. Wagenvoort JH, De Brauwer EI, Penders RJ, Willems RJ, Top J, Bonten MJ (2011) Environmental survival of vancomycin-resistant Enterococcus faecium. J Hosp Infect 77(3):282–283

      Article  CAS  PubMed  Google Scholar 

    50. Ruiz-Garbajosa P, Bonten MJ, Robinson DA et al (2006) Multilocus sequence typing scheme for Enterococcus faecalis reveals hospital-adapted genetic complexes in a background of high rates of recombination. J Clin Microbiol 44(6):2220–2228

      Article  CAS  PubMed  PubMed Central  Google Scholar 

    51. Zhang X, Paganelli FL, Bierschenk D et al (2012) Genome-wide identification of ampicillin resistance determinants in Enterococcus faecium. Plos Genet 8(6):e1002804

      Article  CAS  PubMed  PubMed Central  Google Scholar 

    52. Galloway-Pena JR, Rice LB, Murray BE (2011) Analysis of PBP5 of early U.S. isolates of Enterococcus faecium: sequence variation alone does not explain increasing ampicillin resistance over time. Antimicrob Agents Chemother 55(7):3272–3277

      Article  CAS  PubMed  PubMed Central  Google Scholar 

    53. Rice LB, Carias LL, Hutton-Thomas R, Sifaoui F, Gutmann L, Rudin SD (2001) Penicillin-binding protein 5 and expression of ampicillin resistance in Enterococcus faecium. Antimicrob Agents Chemother 45(5):1480–1486

      Article  CAS  PubMed  PubMed Central  Google Scholar 

    54. Sifaoui F, Arthur M, Rice L, Gutmann L (2001) Role of penicillin-binding protein 5 in expression of ampicillin resistance and peptidoglycan structure in Enterococcus faecium. Antimicrob Agents Chemother 45(9):2594–2597

      Article  CAS  PubMed  PubMed Central  Google Scholar 

    55. García-Solache M, Lebreton F, McLaughlin RE, Whiteaker JD, Gilmore MS, Rice LB (2016) Homologous recombination within large chromosomal regions facilitates acquisition of β-lactam and vancomycin resistance in Enterococcus faecium. Antimicrob Agents Chemother 60(10):5777–5786

      Article  CAS  PubMed  PubMed Central  Google Scholar 

    56. Robert Koch-Institut (RKI) (2017) ARS - Antibiotika-Resistenz-Surveillance. Resistenzentwicklung. https://ars.rki.de/Content/Database/ResistanceDevelopment.aspx . Zugegriffen: 22. März 2018

      Google Scholar 

    57. Robert Koch-Institut (RKI), Klare I, Werner G (2015) Eigenschaften, Häufigkeit und Verbreitung von Vancomycin-resistenten Enterokokken (VRE) in Deutschland. Update 2013/2014. Epid Bull 40:439–435

      Google Scholar 

    58. Werner G, Coque TM, Hammerum AM et al (2008) Emergence and spread of vancomycin resistance among enterococci in Europe. Euro Surveill 13(47):pii: 19046

      Google Scholar 

    59. Willems RJ, van Schaik W (2009) Transition of Enterococcus faecium from commensal organism to nosocomial pathogen. Future Microbiol 4(9):1125–1135

      Article  PubMed  Google Scholar 

    60. European Centre for Disease Prevention and Control (ECDC) (2016) Data from the ECDC Surveillance Atlas - antimicrobial resistance. https://ecdc.europa.eu/en/antimicrobial-resistance/surveillance-and-disease-data/data-ecdc . Zugegriffen: 22. März 2018

      Google Scholar 

    61. Hodel-Christian SL, Murray BE (1991) Characterization of the gentamicin resistance transposon Tn5281 from Enterococcus faecalis and comparison to staphylococcal transposons Tn4001 and Tn4031. Antimicrob Agents Chemother 35(6):1147–1152

      Article  CAS  PubMed  PubMed Central  Google Scholar 

    62. Naser SM, Vancanneyt M, Hoste B, Snauwaert C, Vandemeulebroecke K, Swings J (2006) Reclassification of Enterococcus flavescens Pompei et al. 1992 as a later synonym of Enterococcus casseliflavus (ex Vaughan et al. 1979) Collins et al. 1984 and Enterococcus saccharominimus Vancanneyt et al. 2004 as a later synonym of Enterococcus italicus Fortina et al. 2004. Int J Syst Evol Microbiol 56(Pt 2):413-416

    63. Freitas AR, Tedim AP, Francia MV et al (2016) Multilevel population genetic analysis of vanA and vanB Enterococcus faecium causing nosocomial outbreaks in 27 countries (1986-2012). J Antimicrob Chemother 71(12):3351–3366

      Article  CAS  PubMed  Google Scholar 

    64. Conlan S, Thomas PJ, Deming C et al (2014) Single-molecule sequencing to track plasmid diversity of hospital-associated carbapenemase-producing Enterobacteriaceae. Sci Transl Med 6(254):254ra126

      Article  CAS  PubMed  PubMed Central  Google Scholar 

    65. Sivertsen A, Billstrom H, Melefors O et al (2014) A multicentre hospital outbreak in Sweden caused by introduction of a vanB2 transposon into a stably maintained pRUM-plasmid in an Enterococcus faecium ST192 clone. PLoS ONE 9(8):e103274

      Article  CAS  PubMed  PubMed Central  Google Scholar 

    66. Holmes NE, Ballard SA, Lam MM et al (2013) Genomic analysis of teicoplanin resistance emerging during treatment of vanB vancomycin-resistant Enterococcus faecium infections in solid organ transplant recipients including donor-derived cases. J Antimicrob Chemother 68(9):2134–2139

      Article  CAS  PubMed  Google Scholar 

    67. Werner G, Fleige C, Ewert B, Laverde-Gomez JA, Klare I, Witte W (2010) High-level ciprofloxacin resistance among hospital-adapted Enterococcus faecium (CC17). Int J Antimicrob Agents 35(2):119–125

      Article  CAS  PubMed  Google Scholar 

    68. Willems RJ, Top J, van Schaik W et al (2012) Restricted gene flow among hospital subpopulations of Enterococcus faecium. MBio 3(4):e00151-12

      Article  CAS  PubMed  PubMed Central  Google Scholar 

    69. Willems RJ, Homan W, Top J et al (2001) Variant esp gene as a marker of a distinct genetic lineage of vancomycin-resistant Enterococcus faecium spreading in hospitals. Lancet 357(9259):853–855

      Article  CAS  PubMed  Google Scholar 

    70. Rice LB, Carias L, Rudin S et al (2003) A potential virulence gene, hylEfm, predominates in Enterococcus faecium of clinical origin. J Infect Dis 187(3):508–512

      Article  CAS  PubMed  Google Scholar 

    71. Raven KE, Gouliouris T, Brodrick H et al (2017) Complex routes of nosocomial Vancomycin-resistant Enterococcus faecium transmission revealed by genome sequencing. Clin Infect Dis 64(7):886–893

      Article  PubMed  PubMed Central  Google Scholar 

    72. Bender JK, Kalmbach A, Fleige C, Klare I, Fuchs S, Werner G (2016) Population structure and acquisition of the vanB resistance determinant in German clinical isolates of Enterococcus faecium ST192. Sci Rep 6:21847

      Article  CAS  PubMed  PubMed Central  Google Scholar 

    73. Klare I, Konstabel C, Mueller-Bertling S et al (2005) Spread of ampicillin/vancomycin-resistant Enterococcus faecium of the epidemic-virulent clonal complex-17 carrying the genes esp and hyl in German hospitals. Eur J Clin Microbiol Infect Dis 24(12):815

      Article  CAS  PubMed  Google Scholar 

    74. Ballard SA, Pertile KK, Lim M, Johnson PD, Grayson ML (2005) Molecular characterization of vanB elements in naturally occurring gut anaerobes. Antimicrob Agents Chemother 49(5):1688–1694

      Article  CAS  PubMed  PubMed Central  Google Scholar 

    75. Graham M, Ballard SA, Grabsch EA, Johnson PD, Grayson ML (2008) High rates of fecal carriage of nonenterococcal vanB in both children and adults. Antimicrob Agents Chemother 52(3):1195–1197

      Article  CAS  PubMed  PubMed Central  Google Scholar 

    76. Klare I, Fleige C, Geringer U, Witte W, Werner G (2012) Performance of three chromogenic VRE screening agars, two Etest® vancomycin protocols, and different microdilution methods in detecting vanB genotype Enterococcus faecium with varying vancomycin MICs. Diagn Microbiol Infect Dis 74(2):171–176

      Article  CAS  PubMed  Google Scholar 

    77. European Centre for Disease Prevention and Control (ECDC) (2017) Annual surveillance reports on antimicrobial resistance. https://ecdc.europa.eu/en/antimicrobial-resistance/surveillance-and-disease-data/report . Zugegriffen: 22. März 2018

      Google Scholar 

    78. Robert Koch-Institut (RKI) (2017) ARS - Antibiotika-Resistenz-Surveillance. https://ars.rki.de/ . Zugegriffen: 22. März 2018

      Google Scholar 

    79. Paul-Ehrlich-Gesellschaft für Chemotherapie e.V.(PEG), Arbeitsgemeinschaft Empfindlichkeitsprüfungen und Resistenz (2017) Resistenzdaten. http://www.p-e-g.org/econtext/resistenzdaten . Zugegriffen: 22. März 2018

      Google Scholar 

    80. Surveillance der Antibiotika-Anwendung und bakteriellen Resistenzen auf Intensivstationen (SARI) (2018) SARI - Resistenzdaten. http://sari.eu-burden.info/rr.php . Zugegriffen: 22. März 2018

      Google Scholar 

    81. Noll I, Schweickert B, Abu SM, Feig M, Claus H, Eckmanns T (2012) Daten zur Antibiotikaresistenzlage in Deutschland. Vier Jahre Antibiotika-Resistenz-Surveillance (ARS). Bundesgesundheitsblatt 55(11-12):1370–1376

      Article  CAS  Google Scholar 

    82. Werner G, Klare I, Fleige C et al (2012) Vancomycin-resistant vanB-type Enterococcus faecium isolates expressing varying levels of vancomycin resistance and being highly prevalent among neonatal patients in a single ICU. Antimicrob Resist Infect Control 1(1):21

      Article  PubMed  PubMed Central  Google Scholar 

    83. Whelton E, Lynch C, O'Reilly B et al (2016) Vancomycin-resistant enterococci carriage in an acute Irish hospital. J Hosp Infect 93(2):175–180

      Article  CAS  PubMed  Google Scholar 

    84. de Niederhäusern S, Bondi M, Messi P et al (2011) Vancomycin-resistance transferability from VanA enterococci to Staphylococcus aureus. Curr Microbiol 62(5):1363–1367

      Article  CAS  PubMed  Google Scholar 

    85. Centers for Disease Control and Prevention (CDC) (2002) Staphylococcus aureus resistant to vancomycin - United States, 2002. MMWR Morb Mortal Wkly Rep 51(26):565–567

      Google Scholar 

    86. Walters MS, Eggers P, Albrecht V et al (2015) Notes from the Field: Vancomycin-Resistant Staphylococcus aureus - Delaware, 2015. Mmwr Morb Mortal Wkly Rep 64(37):1056

      Article  PubMed  Google Scholar 

    87. Faron ML, Ledeboer NA, Buchan BW (2016) Resistance mechanisms, epidemiology, and approaches to screening for Vancomycin-resistant Enterococcus in the health care setting. J Clin Microbiol 54(10):2436–2447

      Article  CAS  PubMed  PubMed Central  Google Scholar 

    88. Melo-Cristino J, Resina C, Manuel V, Lito L, Ramirez M (2013) First case of infection with vancomycin-resistant Staphylococcus aureus in Europe. Lancet 382(9888):205

      Article  PubMed  Google Scholar 

    89. Norrby R (2001) Linezolid - a review of the first oxazolidinone. Expert Opin Pharmacother 2(2):293–302

      Article  CAS  PubMed  Google Scholar 

    90. Burdette SD, Trotman R (2015) Tedizolid: the first once-daily Oxazolidinone class antibiotic. Clin Infect Dis 61(8):1315–1321

      Article  CAS  PubMed  Google Scholar 

    91. Tewhey R, Gu B, Kelesidis T et al (2014) Mechanisms of linezolid resistance among coagulase-negative staphylococci determined by whole-genome sequencing. MBio 5(3):e894–14

      Article  CAS  PubMed  PubMed Central  Google Scholar 

    92. Gu B, Kelesidis T, Tsiodras S, Hindler J, Humphries RM (2013) The emerging problem of linezolid-resistant Staphylococcus. J Antimicrob Chemother 68(1):4–11

      Article  CAS  PubMed  Google Scholar 

    93. Bender J, Strommenger B, Steglich M et al (2015) Linezolid resistance in clinical isolates of staphylococcus epidermidis from German hospitals and characterization of two cfr-carrying plasmids. J Antimicrob Chemother 70(6):1630–1638

      CAS  PubMed  PubMed Central  Google Scholar 

    94. Cuny C, Arnold P, Hermes J et al (2017) Occurrence of cfr-mediated multiresistance in staphylococci from veal calves and pigs, from humans at the corresponding farms, and from veterinarians and their family members. Vet Microbiol 200:88–94

      Article  CAS  PubMed  Google Scholar 

    95. Liu Y, Wang Y, Schwarz S et al (2014) Investigation of a multiresistance gene cfr that fails to mediate resistance to phenicols and oxazolidinones in Enterococcus faecalis. J Antimicrob Chemother 69(4):892–898

      Article  CAS  PubMed  Google Scholar 

    96. Bender JK, Fleige C, Klare I et al (2016) Detection of a cfr(B) variant in German Enterococcus faecium clinical isolates and the impact on Linezolid resistance in Enterococcus spp. PLoS ONE 11(11):e167042

      Article  CAS  PubMed  PubMed Central  Google Scholar 

    97. Klare I, Fleige C, Geringer U et al (2015) Increased frequency of linezolid resistance among clinical Enterococcus faecium isolates from German hospital patients. J Glob Antimicrob Resist 3(2):128–131

      Article  PubMed  Google Scholar 

    98. Rubinstein E, Vaughan D (2005) Tigecycline: a novel glycylcycline. Drugs 65(10):1317–1336

      Article  CAS  PubMed  Google Scholar 

    99. Frampton JE, Curran MP (2005) Tigecycline. Drugs 65(18):2623–2635

      Article  CAS  PubMed  Google Scholar 

    100. Entenza JM, Moreillon P (2009) Tigecycline in combination with other antimicrobials: a review of in vitro, animal and case report studies. Int J Antimicrob Agents 34(1):8.e1–8.e9

      Article  CAS  Google Scholar 

    101. Jenkins I (2007) Linezolid- and vancomycin-resistant Enterococcus faecium endocarditis: successful treatment with tigecycline and daptomycin. J Hosp Med 2(5):343–344

      Article  PubMed  Google Scholar 

    102. Polidori M, Nuccorini A, Tascini C et al (2011) Vancomycin-resistant Enterococcus faecium (VRE) bacteremia in infective endocarditis successfully treated with combination daptomycin and tigecycline. J Chemother 23(4):240–241

      Article  CAS  PubMed  Google Scholar 

    103. Jaspan HB, Brothers AW, Campbell AJ et al (2010) Multidrug-resistant Enterococcus faecium meningitis in a toddler: characterization of the organism and successful treatment with intraventricular daptomycin and intravenous tigecycline. Pediatr Infect Dis J 29(4):379–381

      PubMed  PubMed Central  Google Scholar 

    104. Shen F, Han Q, Xie D, Fang M, Zeng H, Deng Y (2015) Efficacy and safety of tigecycline for the treatment of severe infectious diseases: an updated meta-analysis of RCTs. Int J Infect Dis 39:25–33

      Article  CAS  PubMed  Google Scholar 

    105. Fiedler S, Bender JK, Klare I et al (2016) Tigecycline resistance in clinical isolates of Enterococcus faecium is mediated by an upregulation of plasmid-encoded tetracycline determinants tet(L) and tet(M). J Antimicrob Chemother 71(4):871–881

      Article  CAS  PubMed  Google Scholar 

    106. Niebel M, Quick J, Prieto AM et al (2015) Deletions in a ribosomal protein-coding gene are associated with tigecycline resistance in Enterococcus faecium. Int J Antimicrob Agents 46(5):572–575

      Article  CAS  PubMed  Google Scholar 

    107. Werner G, Gfrorer S, Fleige C, Witte W, Klare I (2008) Tigecycline-resistant Enterococcus faecalis strain isolated from a German intensive care unit patient. J Antimicrob Chemother 61(5):1182–1183

      Article  CAS  PubMed  Google Scholar 

    108. Lee SY, Fan HW, Kuti JL, Nicolau DP (2006) Update on daptomycin: the first approved lipopeptide antibiotic. Expert Opin Pharmacother 7(10):1381–1397

      Article  CAS  PubMed  Google Scholar 

    109. The European Committee on Antimicrobial Susceptibility Testing (EUCAST) (2016) Guidance document on use of daptomycin to treat enterococcal endocarditis. http://www.eucast.org/fileadmin/src/media/PDFs/EUCAST_files/General_documents/EUCAST_daptomycin_guidance_note_20160302.pdf . Zugegriffen: 22. März 2018

      Google Scholar 

    110. Ceron I, Munoz P, Marin M et al (2014) Efficacy of daptomycin in the treatment of enterococcal endocarditis: a 5 year comparison with conventional therapy. J Antimicrob Chemother 69(6):1669–1674

      Article  CAS  PubMed  Google Scholar 

    111. Shukla BS, Shelburne S, Reyes K et al (2016) Influence of minimum inhibitory concentration in clinical outcomes of Enterococcus faecium Bacteremia treated with Daptomycin: is it time to change the breakpoint? Clin Infect Dis 62(12):1514–1520

      Article  CAS  PubMed  PubMed Central  Google Scholar 

    112. Snyder AH, Werth BJ, Barber KE, Sakoulas G, Rybak MJ (2014) Evaluation of the novel combination of daptomycin plus ceftriaxone against vancomycin-resistant enterococci in an in vitro pharmacokinetic/pharmacodynamic simulated endocardial vegetation model. J Antimicrob Chemother 69(8):2148–2154

      Article  CAS  Google Scholar 

    113. Hindler JA, Wong-Beringer A, Charlton CL et al (2015) In vitro activity of daptomycin in combination with beta-lactams, gentamicin, rifampin, and tigecycline against daptomycin-nonsusceptible enterococci. Antimicrob Agents Chemother 59(7):4279–4288

      Article  CAS  PubMed  PubMed Central  Google Scholar 

    114. Desai H, Wong R, Pasha AK (2016) A novel way of treating multidrug-resistant Enterococci. N Am J Med Sci 8(5):229–231

      Article  PubMed  PubMed Central  Google Scholar 

    115. Chuang YC, Chen PY, Lin CY, Chen YC, Wang JT, Chang SC (2018) A retrospective clinical comparison of daptomycin vs daptomycin and a beta-lactam antibiotic for treating vancomycin-resistant Enterococcus faecium bloodstream infections. Sci Rep 8(1):1632

      Article  CAS  PubMed  PubMed Central  Google Scholar 

    116. Tran TT, Munita JM, Arias CA (2015) Mechanisms of drug resistance: daptomycin resistance. Ann N Y Acad Sci 1354:32–53

      Article  PubMed  PubMed Central  Google Scholar 

    117. Werth BJ, Steed ME, Ireland CE et al (2014) Defining daptomycin resistance prevention exposures in vancomycin-resistant Enterococcus faecium and E. faecalis. Antimicrob Agents Chemother 58(9):5253–5261

      Article  CAS  PubMed  PubMed Central  Google Scholar 

    118. Tran TT, Panesso D, Gao H et al (2013) Whole-genome analysis of a daptomycin-susceptible Enterococcus faecium strain and its daptomycin-resistant variant arising during therapy. Antimicrob Agents Chemother 57(1):261–268

      Article  CAS  PubMed  PubMed Central  Google Scholar 

    119. Arias CA, Panesso D, McGrath DM et al (2011) Genetic basis for in vivo daptomycin resistance in enterococci. N Engl J Med 365(10):892–900

      Article  CAS  PubMed  PubMed Central  Google Scholar 

    120. Lellek H, Franke GC, Ruckert C et al (2015) Emergence of daptomycin non-susceptibility in colonizing vancomycin-resistant Enterococcus faecium isolates during daptomycin therapy. Int J Med Microbiol 305(8):902–909

      Article  CAS  PubMed  Google Scholar 

    121. Donskey CJ, Chowdhry TK, Hecker MT et al (2000) Effect of antibiotic therapy on the density of vancomycin-resistant enterococci in the stool of colonized patients. N Engl J Med 343(26):1925–1932

      Article  CAS  PubMed  PubMed Central  Google Scholar 

    122. Ubeda C, Taur Y, Jenq RR et al (2010) Vancomycin-resistant Enterococcus domination of intestinal microbiota is enabled by antibiotic treatment in mice and precedes bloodstream invasion in humans. J Clin Invest 120(12):4332–4341

      Article  CAS  PubMed  PubMed Central  Google Scholar 

    123. Taur Y, Xavier JB, Lipuma L et al (2012) Intestinal domination and the risk of bacteremia in patients undergoing allogeneic hematopoietic stem cell transplantation. Clin Infect Dis 55(7):905–914

      Article  CAS  PubMed  PubMed Central  Google Scholar 

    124. Buffie CG, Pamer EG (2013) Microbiota-mediated colonization resistance against intestinal pathogens. Nat Rev Immunol 13(11):790–801

      Article  CAS  PubMed  PubMed Central  Google Scholar 

    125. Hooton TM, Roberts PL, Cox ME, Stapleton AE (2013) Voided midstream urine culture and acute cystitis in premenopausal women. N Engl J Med 369(20):1883–1891

      Article  CAS  PubMed  PubMed Central  Google Scholar 

    126. Ziakas P, Pliakos E, Zervou F, Knoll B, Rice L, Mylonakis E (2014) MRSA and VRE colonization in solid organ transplantation: a meta-analysis of published studies. Am J Transplant 14(8):1887–1894

      Article  CAS  PubMed  Google Scholar 

    127. Ong DS, Bonten MJ, Safdari K et al (2015) Epidemiology, management, and risk-adjusted mortality of ICU-acquired Enterococcal Bacteremia. Clin Infect Dis 61(9):1413–1420

      Article  PubMed  Google Scholar 

    128. Dupont H, Friggeri A, Touzeau J et al (2011) Enterococci increase the morbidity and mortality associated with severe intra-abdominal infections in elderly patients hospitalized in the intensive care unit. J Antimicrob Chemother 66:2379–2385

      Article  CAS  PubMed  Google Scholar 

    129. Kaffarnik MF, Urban M, Hopt UT, Utzolino S (2012) Impact of enterococcus on immunocompetent and immunosuppressed patients with perforation of the small or large bowel. Technol Health Care 20(1):37–48

      PubMed  PubMed Central  Google Scholar 

    130. Jindai K, Strerath M, Hess T, Safdar N (2014) Is a single positive blood culture for Enterococcus species representative of infection or contamination? Eur J Clin Microbiol Infect Dis 33(11):1995–2003

      Article  CAS  PubMed  Google Scholar 

    131. Grundmann H, Bärwolff S, Tami A et al (2005) How many infections are caused by patient-to-patient transmission in intensive care units? Crit Care Med 33(5):946–951

      Article  PubMed  Google Scholar 

    132. Kola A, Schwab F, Bärwolff S et al (2010) Is there an association between nosocomial infection rates and bacterial cross transmissions? Crit Care Med 38(1):46–50

      Article  PubMed  Google Scholar 

    133. Erb S, Frei R, Dangel M, Widmer AF (2017) Multidrug-resistant organisms detected more than 48 hours after hospital admission are not necessarily hospital-acquired. Infect Control Hosp Epidemiol 38(1):18–23

      Article  PubMed  Google Scholar 

    134. Cheng VC, Tai JW, Ng ML et al (2012) Extensive contact tracing and screening to control the spread of vancomycin-resistant Enterococcus faecium ST414 in Hong Kong. Chin Med J 125(19):3450–3457

      PubMed  PubMed Central  Google Scholar 

    135. Kurup A, Chlebicki M, Ling M et al (2008) Control of a hospital-wide vancomycin-resistant Enterococci outbreak. Am J Infect Control 36(3):206–211

      Article  PubMed  Google Scholar 

    136. Kaki R, Yu Y, O’Neill C, Lee C, Mertz D (2014) Vancomycin-resistant enterococcus (VRE) transmission and risk factors in contacts of VRE carriers. Infect Control Hosp Epidemiol 35(07):876–879

      Article  PubMed  Google Scholar 

    137. Zhou Q, Moore C, Eden S, Tong A, McGeer A (2008) Factors associated with acquisition of vancomycin-resistant enterococci (VRE) in roommate contacts of patients colonized or infected with VRE in a tertiary care hospital. Infect Control Hosp Epidemiol 29(05):398–403

      Article  PubMed  Google Scholar 

    138. Austin DJ, Bonten MJ (1998) Vancomycin-resistant enterococci in intensive care hospital settings. Mem Inst Oswaldo Cruz 93(5):587–588

      Article  CAS  PubMed  Google Scholar 

    139. Duckro AN, Blom DW, Lyle EA, Weinstein RA, Hayden MK (2005) Transfer of vancomycin-resistant enterococci via health care worker hands. Arch Intern Med 165(3):302–307

      Article  PubMed  Google Scholar 

    140. Bonten MJ, Hayden MK, Nathan C et al (1996) Epidemiology of colonisation of patients and environment with vancomycin-resistant enterococci. Lancet 348(9042):1615–1619

      Article  CAS  PubMed  Google Scholar 

    141. Gray J, George R (2000) Experience of vancomycin-resistant enterococci in a children's hospital. J Hosp Infect 45(1):11–18

      Article  CAS  PubMed  Google Scholar 

    142. McCarthy K, Van Nierop W, Duse A et al (2000) Control of an outbreak of vancomycin-resistant Enterococcus faecium in an oncology ward in South Africa: effective use of limited resources. J Hosp Infect 44(4):294–300

      Article  CAS  PubMed  Google Scholar 

    143. Hanna H, Umphrey J, Tarrand J, Mendoza M, Raad I (2001) Management of an outbreak of vancomycin-resistant enterococci in the medical intensive care unit of a cancer center. Infect Control Hosp Epidemiol 22(04):217–219

      Article  CAS  PubMed  Google Scholar 

    144. Martinez JA, Ruthazer R, Hansjosten K, Barefoot L, Snydman DR (2003) Role of environmental contamination as a risk factor for acquisition of vancomycin-resistant enterococci in patients treated in a medical intensive care unit. Arch Intern Med 163(16):1905–1912

      Article  PubMed  Google Scholar 

    145. Lemmen S, Häfner H, Zolldann D, Stanzel S, Lütticken R (2004) Distribution of multi-resistant Gram-negative versus Gram-positive bacteria in the hospital inanimate environment. J Hosp Infect 56(3):191–197

      Article  CAS  PubMed  Google Scholar 

    146. Rhinehart E, Smith NE, Wennersten C et al (1990) Rapid dissemination of β-Lactamase–producing, Aminoglycoside-resistant Enterococcus faecalis among patients and staff on an infant–toddler surgical ward. N Engl J Med 323(26):1814–1818

      Article  CAS  PubMed  Google Scholar 

    147. Boyce JM, Opal SM, Chow JW et al (1994) Outbreak of multidrug-resistant Enterococcus faecium with transferable vanB class vancomycin resistance. J Clin Microbiol 32(5):1148–1153

      CAS  PubMed  PubMed Central  Google Scholar 

    148. Schulz-Stübner S, Schmidt-Warnecke A, Hwang JH (2013) VRE transmission via the reusable breathing circuit of a transport ventilator: outbreak analysis and experimental study of surface disinfection. Intensive Care Med 39(5):975–976

      Article  PubMed  Google Scholar 

    149. Golan Y, Doron S, Sullivan B, Snydman DR (2005) Transmission of vancomycin-resistant enterococcus in a neonatal intensive care unit. Pediatr Infect Dis J 24(6):566–567

      Article  PubMed  Google Scholar 

    150. Porwancher R, Sheth A, Remphrey S, Taylor E, Hinkle C, Zervos M (1997) Epidemiological study of hospital-acquired infection with vancomycin-resistant Enterococcus faecium: possible transmission by an electronic ear-probe thermometer. Infect Control Hosp Epidemiol 18(11):771–773

      Article  CAS  PubMed  Google Scholar 

    151. Livornese LL Jr., Dias S, Samel C et al (1992) Hospital-acquired infection with vancomycin-resistant Enterococcus faecium transmitted by electronic thermometers. Ann Intern Med 117(2):112–116

      Article  PubMed  Google Scholar 

    152. Lee SC, Wu MS, Shih HJ et al (2013) Identification of vancomycin-resistant enterococci clones and inter-hospital spread during an outbreak in Taiwan. BMC Infect Dis 13:163

      Article  CAS  PubMed  PubMed Central  Google Scholar 

    153. Falk PS, Winnike J, Woodmansee C, Desai M, Mayhall CG (2000) Outbreak of vancomycin-resistant enterococci in a burn unit. Infect Control Hosp Epidemiol 21(9):575–582

      Article  CAS  PubMed  Google Scholar 

    154. Huang SS, Datta R, Platt R (2006) Risk of acquiring antibiotic-resistant bacteria from prior room occupants. Arch Intern Med 166(18):1945–1951

      Article  PubMed  Google Scholar 

    155. Drees M, Snydman DR, Schmid CH et al (2008) Prior environmental contamination increases the risk of acquisition of vancomycin-resistant enterococci. Clin Infect Dis 46(5):678–685

      Article  CAS  PubMed  Google Scholar 

    156. Noble MA, Isaac-Renton JL, Bryce EA et al (1998) The toilet as a transmission vector of vancomycin-resistant enterococci. J Hosp Infect 40(3):237–241

      Article  CAS  PubMed  Google Scholar 

    157. Wendt C, Ruden H, Edmond M (1998) Vancomycin-resistente Enterokokken Epidemiologie, Risikofaktoren und Pravention. Dtsch Arztebl 95(25):A-1604–A1610

      Google Scholar 

    158. Gerba CP, Wuollet AL, Raisanen P, Lopez GU (2016) Bacterial contamination of computer touch screens. Am J Infect Control 44(3):358–360

      Article  PubMed  Google Scholar 

    159. Schultz M, Gill J, Zubairi S, Huber R, Gordin F (2003) Bacterial contamination of computer keyboards in a teaching hospital. Infect Control Hosp Epidemiol 24(4):302–303

      Article  PubMed  Google Scholar 

    160. Koroglu M, Gunal S, Yildiz F, Savas M, Ozer A, Altindis M (2015) Comparison of keypads and touch-screen mobile phones/devices as potential risk for microbial contamination. J Infect Dev Ctries 9(12):1308–1314

      Article  PubMed  Google Scholar 

    161. Kandel CE, Simor AE, Redelmeier DA (2014) Elevator buttons as unrecognized sources of bacterial colonization in hospitals. Open Med 8(3):e81–86

      PubMed  PubMed Central  Google Scholar 

    162. Hayden MK, Blom DW, Lyle EA, Moore CG, Weinstein RA (2008) Risk of hand or glove contamination after contact with patients colonized with vancomycin-resistant enterococcus or the colonized patients' environment. Infect Control Hosp Epidemiol 29(2):149–154

      Article  PubMed  Google Scholar 

    163. Morgan DJ, Rogawski E, Thom KA et al (2012) Transfer of multidrug-resistant bacteria to healthcare workers’ gloves and gowns after patient contact increases with environmental contamination. Crit Care Med 40(4):1045

      Article  PubMed  PubMed Central  Google Scholar 

    164. Whitman MS, Pitsakis PG, DeJesus E, Osborne AJ, Levison ME, Johnson CC (1996) Gastrointestinal tract colonization with vancomycin-resistant Enterococcus faecium in an animal model. Antimicrob Agents Chemother 40(6):1526–1530

      CAS  PubMed  PubMed Central  Google Scholar 

    165. Dancer SJ (2014) Controlling hospital-acquired infection: focus on the role of the environment and new technologies for decontamination. Clin Microbiol Rev 27(4):665–690

      Article  CAS  PubMed  PubMed Central  Google Scholar 

    166. Monteserin N, Larson E (2016) Temporal trends and risk factors for healthcare-associated vancomycin-resistant enterococci in adults. J Hosp Infect 94(3):236–241

      Article  CAS  PubMed  PubMed Central  Google Scholar 

    167. Humphreys H (2014) Controlling the spread of vancomycin-resistant enterococci. Is active screening worthwhile? J Hosp Infect 88(4):191–198

      Article  CAS  PubMed  Google Scholar 

    168. Cohen MJ, Adler A, Block C et al (2009) Acquisition of vancomycin-resistant enterococci in internal medicine wards. Am J Infect Control 37(2):111–116

      Article  PubMed  Google Scholar 

    169. Rabinowitz RP, Kufera JA, Makley MJ (2012) A hidden reservoir of methicillin-resistant Staphylococcus aureus and vancomycin-resistant Enterococcus in patients newly admitted to an acute rehabilitation hospital. PM R 4(1):18–22

      Article  PubMed  Google Scholar 

    170. Carmeli Y, Eliopoulos GM, Samore MH (2002) Antecedent treatment with different antibiotic agents as a risk factor for vancomycin-resistant Enterococcus. Emerging Infect Dis 8(8):802–807

      Article  CAS  PubMed  PubMed Central  Google Scholar 

    171. Paterson DL, Muto CA, Ndirangu M et al (2008) Acquisition of rectal colonization by vancomycin-resistant Enterococcus among intensive care unit patients treated with piperacillin-tazobactam versus those receiving cefepime-containing antibiotic regimens. Antimicrob Agents Chemother 52(2):465–469

      Article  CAS  PubMed  Google Scholar 

    172. Hayakawa K, Marchaim D, Palla M et al (2013) Epidemiology of vancomycin-resistant Enterococcus faecalis: a case-case-control study. Antimicrob Agents Chemother 57(1):49–55

      Article  CAS  PubMed  PubMed Central  Google Scholar 

    173. Ajao AO, Harris AD, Roghmann M-C et al (2011) Systematic review of measurement and adjustment for colonization pressure in studies of methicillin-resistant Staphylococcus aureus, vancomycin-resistant enterococci, and Clostridium difficile acquisition. Infect Control Hosp Epidemiol 32(5):481

      Article  PubMed  PubMed Central  Google Scholar 

    174. Tacconelli E, Karchmer AW, Yokoe D, D'agata EM (2004) Preventing the influx of vancomycin-resistant enterococci into health care institutions, by use of a simple validated prediction rule. Clin Infect Dis 39(7):964–970

      Article  PubMed  Google Scholar 

    175. Decker BK, Lau AF, Dekker JP et al (2017) Healthcare personnelintestinal colonization with multidrug-resistant organisms. Clin Microbiol Infect 24(1):82.e1–82.e4

      Article  Google Scholar 

    176. Baran J Jr., Ramanathan J, Riederer KM, Khatib R (2002) Stool colonization with vancomycin-resistant enterococci in healthcare workers and their households. Infect Control Hosp Epidemiol 23(1):23–26

      Article  CAS  PubMed  Google Scholar 

    177. Montecalvo MA, de Lencastre H, Carraher M et al (1995) Natural history of colonization with vancomycin-resistant Enterococcus faecium. Infect Control Hosp Epidemiol 16(12):680–685

      Article  CAS  PubMed  Google Scholar 

    178. Kim AS (2011) Using the good to beat out the bad: probiotics for eliminating vancomycin-resistant enterococci colonization. J Clin Gastroenterol 45(10):844–845

      Article  PubMed  Google Scholar 

    179. Baden L, Thiemke W, Skolnik A et al (2001) Prolonged colonization with vancomycin-resistant Enterococcus faecium in long-term care patients and the significance of “clearance”. Clin Infect Dis 33(10):1654–1660

      Article  CAS  PubMed  Google Scholar 

    180. Shenoy ES, Paras ML, Noubary F, Walensky RP, Hooper DC (2014) Natural history of colonization with methicillin-resistant Staphylococcus aureus (MRSA) and vancomycin-resistant Enterococcus (VRE): a systematic review. BMC Infect Dis 14(1):177

      Article  CAS  PubMed  PubMed Central  Google Scholar 

    181. Sohn KM, Peck KR, Joo EJ et al (2013) Duration of colonization and risk factors for prolonged carriage of vancomycin-resistant enterococci after discharge from the hospital. Int J Infect Dis 17(4):e240–246

      Article  PubMed  Google Scholar 

    182. Karki S, Land G, Aitchison S et al (2013) Long-term carriage of vancomycin-resistant enterococci in patients discharged from hospitals: a 12-year retrospective cohort study. J Clin Microbiol 51(10):3374–3379

      Article  PubMed  PubMed Central  Google Scholar 

    183. Nourse C, Byrne C, Murphy H, Kaufmann M, Clarke A, Butler K (2000) Eradication of vancomycin resistant Enterococcus faecium from a paediatric oncology unit and prevalence of colonization in hospitalized and community-based children. Epidemiol Infect 124(01):53–59

      Article  CAS  PubMed  PubMed Central  Google Scholar 

    184. Henning KJ, Delencastre H, Eagan J et al (1996) Vancomycin-resistant Enterococcus faecium on a pediatric oncology ward: duration of stool shedding and incidence of clinical infection. Pediatr Infect Dis J 15(10):848–854

      Article  CAS  PubMed  Google Scholar 

    185. Schuster F, Graubner UB, Schmid I, Weiss M, Belohradsky BH (1998) Vancomycin-resistant-enterococci-colonization of 24 patients on a pediatric oncology unit. Klin Padiatr 210(04):261–263

      Article  CAS  PubMed  Google Scholar 

    186. Hopkins HA, Sinkowitz-Cochran RL, Rudin BA, Keyserling HL, Jarvis WR (2000) Vancomycin use in pediatric hematology-oncology patients. Infect Control Hosp Epidemiol 21(01):48–50

      Article  CAS  PubMed  Google Scholar 

    187. Lister DM, Tan K, Carse E, Stuart RL (2016) Clearance of infant vancomycin-resistant Enterococcus faecium carriage after a neonatal inpatient outbreak. Am J Infect Control 44(10):1172–1173

      Article  PubMed  Google Scholar 

    188. Ghosh A, Jiao L, Al-Mutawa F et al (2014) Value of an active surveillance policy to document clearance of meticillin-resistant Staphylococcus aureus and vancomycin-resistant enterococci amongst inpatients with prolonged admissions. J Hosp Infect 88(4):230–233

      Article  CAS  PubMed  Google Scholar 

    189. Behnke M, Hansen S, Leistner R et al (2013) Nosocomial infection and antibiotic use. Dtsch Arztebl Int 110:627–633

      PubMed  PubMed Central  Google Scholar 

    190. Nationales Referenzzentrum für die Surveillance von nosokomialen Infektionen (NRZ) (2017) Deutsche nationale Punkt-Prävalenzerhebung zu nosokomialen Infektionen und Antibiotika-Anwendung. 2016. Abschlussbericht. http://www.nrz-hygiene.de/fileadmin/nrz/download/pps2016/PPS_2016_Abschlussbericht_20.07.2017.pdf . Zugegriffen: 22. März 2018

      Google Scholar 

    191. Orsi G, Ciorba V (2013) Vancomycin resistant enterococci healthcare associated infections. Ann Ig 25(6):485–492

      CAS  PubMed  PubMed Central  Google Scholar 

    192. Gudiol C, Ayats J, Camoez M et al (2013) Increase in bloodstream infection due to vancomycin-susceptible Enterococcus faecium in cancer patients: risk factors, molecular epidemiology and outcomes. PLoS ONE 8(9):e74734

      Article  CAS  PubMed  PubMed Central  Google Scholar 

    193. Kresken M, Groll AH, Lass-Flörl C, Körber-Irrgang B (2013) PEG-Resistenzstudie. Epidemiologie und Resistenzsituation bei Candida-Isolaten aus Blut und anderen primär sterilen Körperregionen gegenüber Antimykotika. Bericht über die Ergebnisse einer multizentrischen Studie der Arbeitsgemeinschaft Empfindlichkeitsprüfungen & Resistenz der Paul-Ehrlich-Gesellschaft für Chemotherapie e.V. aus dem Jahre 2010. Antiinfectives Intelligence: Rheinbach. http://www.paul-ehrlich-gesellschaft.de/econtext/Poster%20Publikationen . Zugegriffen: 22. März 2018

    194. Kresken M, Hafner D (1999) Prävalenz der Antibiotikaresistenz bei klinisch wichtigen Infektionserregern in Mitteleuropa. Bericht über die Ergebnisse einer multizentrischen Studie der Arbeitsgemeinschaft ”Resistenz” in der Paul-Ehrlich-Gesellschaft für Chemotherapie e.V. aus dem Jahre 1998. http://www.p-e-g.org/econtext/Berichte%20der%20Studien . Zugegriffen: 22 März 2018

    195. Kresken M, Hafner D, Körber-Irrgang B für die Studiengruppe (2013) PEG-Resistenzstudie. Epidemiologie und Resistenzsituation bei klinisch wichtigen Infektionserregern aus dem Hospitalbereich gegenüber Antibiotika. Bericht über die Ergebnisse einer multizentrischen Studie der Arbeitsgemeinschaft Empfindlichkeitsprüfungen & Resistenz der Paul-Ehrlich-Gesellschaft für Chemotherapie e.V. aus dem Jahre 2010. Antiinfectives Intelligence: Rheinbach. http://www.p-e-g.org/econtext/Berichte%20der%20Studien . Zugegriffen: 22. März 2018

    196. Kresken M, Hafner D, Körber-Irrgang B für die Studiengruppe (2013) PEG-Resistenzstudie. Resistenzsituation bei klinisch wichtigen Infektionserregern aus dem ambulanten Versorgungsbereich gegenüber Antibiotika. Bericht über die Ergebnisse einer multizentrischen Studie der Arbeitsgemeinschaft Empfindlichkeitsprüfungen & Resistenz der Paul-Ehrlich-Gesellschaft für Chemotherapie e.V. aus dem Jahre 2010. Antiinfectives Intelligence: Rheinbach. http://www.p-e-g.org/econtext/Berichte%20der%20Studien . Zugegriffen: 22. März 2018

    197. Kresken M, Hafner D, Körber-Irrgang B für die Studiengruppe (2016) PEG-Resistenzstudie. Epidemiologie und Resistenzsituation bei klinisch wichtigen Infektionserregern aus dem Hospitalbereich gegenüber Antibiotika. Bericht über die Ergebnisse einer multizentrischen Studie der Arbeitsgemeinschaft Empfindlichkeitsprüfungen & Resistenz der Paul-Ehrlich-Gesellschaft für Chemotherapie e.V. aus dem Jahre 2013. Antiinfectives Intelligence: Rheinbach. http://www.p-e-g.org/econtext/Berichte%20der%20Studien . Zugegriffen: 22. März 2018

    198. Kresken M, Hafner D, Körber-Irrgang B für die Studiengruppe (2016) PEG-Resistenzstudie. Epidemiologie und Resistenzsituation bei klinisch wichtigen Infektionserregern aus dem ambulanten Versorgungsbereich gegenüber Antibiotika. Bericht über die Ergebnisse einer multizentrischen Studie der Arbeitsgemeinschaft Empfindlichkeitsprüfungen & Resistenz der Paul-Ehrlich-Gesellschaft für Chemotherapie e.V. aus dem Jahre 2013. Antiinfectives Intelligence: Rheinbach. http://www.p-e-g.org/econtext/Berichte%20der%20Studien . Zugegriffen: 22. März 2018

    199. Kresken M, Hafner D, Schmitz FJ, Wichelhaus TA für die Studiengruppe (2003) PEG-Resistenzstudie. Resistenzsituation bei klinisch wichtigen Infektionserregern gegenüber Antibiotika in Deutschland und im mitteleuropäischen Raum. Bericht über die Ergebnisse einer multizentrischen Studie der Arbeitsgemeinschaft Empfindlichkeitsprüfungen & Resistenz der Paul-Ehrlich-Gesellschaft für Chemotherapie e.V. aus dem Jahre 2001. Antiinfectives Intelligence: Bonn. http://www.p-e-g.org/econtext/Berichte%20der%20Studien . Zugegriffen: 22. März 2018

    200. Kresken M, Hafner D, Schmitz F-J, Wichelhaus TA für die Studiengruppe (2006) PEG-Resistenzstudie. Resistenzsituation bei klinisch wichtigen Infektionserregern gegenüber Antibiotika in Deutschland und im mitteleuropäischen Raum. Bericht über die Ergebnisse einer multizentrischen Studie der Arbeitsgemeinschaft Empfindlichkeitsprüfungen & Resistenz der Paul-Ehrlich-Gesellschaft für Chemotherapie e.V. aus dem Jahre 2004. Antiinfectives Intelligence: Rheinbach. http://www.p-e-g.org/econtext/Berichte%20der%20Studien . Zugegriffen: 22. März 2018

    201. Kresken M, Hafner D, Schmitz F-J, Wichelhaus TA für die Studiengruppe (2009) PEG-Resistenzstudie. Resistenzsituation bei klinisch wichtigen Infektionserregern gegenüber Antibiotika in Deutschland und im mitteleuropäischen Raum. Bericht über die Ergebnisse einer multizentrischen Studie der Arbeitsgemeinschaft Empfindlichkeitsprüfungen & Resistenz der Paul-Ehrlich-Gesellschaft für Chemotherapie e.V. aus dem Jahre 2007. Antiinfectives Intelligence: Rheinbach. http://www.p-e-g.org/econtext/Berichte%20der%20Studien . Zugegriffen: 22. März 2018

    202. Nationales Referenzzentrum für Surveillance von nosokomialen Infektionen (2017) KISS Krankenhaus-Infektions-Surveillance-System. Modul OP-KISS. Referenzdaten. Berechnungszeitraum: Januar 2012 bis Dezember 2016. http://www.nrz-hygiene.de/fileadmin/nrz/module/op/201201_201612_OPRef.pdf . Zugegriffen: 22. März 2018

      Google Scholar 

    203. Pochhammer J, Kramer A, Schaffer M (2017) Enterokokken und postoperative Wundinfektionen. Verursacher oder harmloser Kommensale? Chirurg 88(5):377–384

      Article  CAS  PubMed  Google Scholar 

    204. Nationales Referenzzentrum für Surveillance von nosokomialen Infektionen (2017) KISS Krankenhaus-Infektions-Surveillance-System. Infektionssurveillance im Modul ITS-KISS. Referenzdaten. Berechnungszeitraum: Januar 2012 bis Dezember 2016. http://www.nrz-hygiene.de/fileadmin/nrz/module/its/201201_201612_ALLE_ITSRef.pdf . Zugegriffen: 22. März 2018

      Google Scholar 

    205. Heyde A (2014) Befunde, prädisponierende Faktoren und klinische Verläufe der infektiösen Endokarditis unter Berücksichtigung des Lebensalters. Dissertation, Medizinischen Fakultät Charité – Universitätsmedizin Berlin

    206. Guerrero MLF, Goyenechea A, Verdejo C, Roblas RF, de Górgolas M (2007) Enterococcal endocarditis on native and prosthetic valves: a review of clinical and prognostic factors with emphasis on hospital-acquired infections as a major determinant of outcome. Medicine (Baltimore) 86(6):363–377

      Article  Google Scholar 

    207. Bandyk DF, Novotney ML, Back MR, Johnson BL, Schmacht DC (2001) Expanded application of in situ replacement for prosthetic graft infection. J Vasc Surg 34(3):411–420

      Article  CAS  PubMed  Google Scholar 

    208. Yogev R (2001) Antibiotic therapy of an enterococcal ventriculoperitoneal shunt infection. Pediatr Infect Dis J 20(8):816–817

      Article  CAS  PubMed  Google Scholar 

    209. Barequet IS, Sullivan Baker A, Schein OE (2000) Ocular infections. In: Waldvogel FA, Bisno AL (Hrsg) Infections associated with indwelling medical devices, 3. Aufl. American Society of Microbiology, Washington DC, S 287–306

      Google Scholar 

    210. Bachleda P, Kalinova L, Utikal P, Kolar M, Hricova K, Stosova T (2012) Infected prosthetic dialysis arteriovenous grafts: a single dialysis center study. Surg Infect (Larchmt) 13(6):366–370

      Article  Google Scholar 

    211. Wang JS, Muzevich K, Edmond MB, Bearman G, Stevens MP (2014) Central nervous system infections due to vancomycin-resistant enterococci: case series and review of the literature. Int J Infect Dis 25:26–31

      Article  PubMed  Google Scholar 

    212. Deutsche Gesellschaft für Anästhesiologie und Intensivmedizin (DGAI), Deutsche Gesellschaft für Infektiologie (DGI), Deutsche Gesellschaft für Hygiene und Mikrobiologie (DGHM), Deutsche Gesellschaft für Pneumologie und Beatmungsmedizin (DGP), Paul-Ehrlich Gesellschaft für Chemotherapie (PEG) (2012) S3-Leitlinie 020/013 - Epidemiologie, Diagnostik und Therapie erwachsener Patienten mit nosokomialer Pneumonie (gültig bis 30.09.2017). http://www.awmf.org/leitlinien/detail/ll/020-013.html . Zugegriffen: 22. März 2018

      Google Scholar 

    213. Johnston PB, Litzow MR, Elliott MA et al (2000) Colonization with vancomycin-resistant enterococcus correlates with poor outcome in patients undergoing allogeneic blood and marrow transplants. Blood 96(11):786a–786a

      Google Scholar 

    214. Patel R (2003) Clinical impact of vancomycin-resistant enterococci. J Antimicrob Chemother 51(Suppl 3):iii13–iii21

      CAS  PubMed  PubMed Central  Google Scholar 

    215. Goetz AM, Rihs JD, Wagener MM, Muder RR (1998) Infection and colonization with vancomycin-resistant Enterococcus faecium in an acute care Veterans Affairs Medical Center: a 2-year survey. Am J Infect Control 26(6):558–562

      Article  CAS  PubMed  Google Scholar 

    216. Calfee DP, Giannetta ET, Durbin LJ, Germanson TP, Farr BM (2003) Control of endemic vancomycin-resistant Enterococcus among inpatients at a university hospital. Clin Infect Dis 37(3):326–332

      Article  PubMed  Google Scholar 

    217. Fournier S, Brossier F, Fortineau N et al (2012) Long-term control of vancomycin-resistant Enterococcus faecium at the scale of a large multihospital institution: a seven-year experience. Euro Surveill 17(30):11–17

      Google Scholar 

    218. Datta R, Huang SS (2010) Risk of postdischarge infection with vancomycin-resistant enterococcus after initial infection or colonization. Infect Control Hosp Epidemiol 31(12):1290–1293

      Article  PubMed  PubMed Central  Google Scholar 

    219. Caballero-Granado FJ, Cisneros J, Luque R et al (1998) Comparative study of Bacteremias caused by Enterococcus spp. with and without high-level resistance to Gentamicin. J Clin Microbiol 36(2):520–525

      CAS  PubMed  PubMed Central  Google Scholar 

    220. Jiang HL, Zhou Z, Wang LS, Fang Y, Li YH, Cs C (2017) The risk factors, costs, and survival analysis of invasive VRE infections at a medical center in eastern Taiwan. Int J Infect Dis 54:18–24

      Article  PubMed  Google Scholar 

    221. Hefazi M, Damlaj M, Alkhateeb HB et al (2016) Vancomycin-resistant Enterococcus colonization and bloodstream infection: prevalence, risk factors, and the impact on early outcomes after allogeneic hematopoietic cell transplantation in patients with acute myeloid leukemia. Transpl Infect Dis 18(6):913–920

      Article  CAS  PubMed  Google Scholar 

    222. Cheah A, Spelman T, Liew D et al (2013) Enterococcal bacteraemia: factors influencing mortality, length of stay and costs of hospitalization. Clin Microbiol Infect 19(4):E181–E189

      Article  CAS  PubMed  Google Scholar 

    223. Furtado GH, Mendes RE, Pignatari AC, Wey SB, Medeiros EA (2006) Risk factors for vancomycin-resistant Enterococcus faecalis bacteremia in hospitalized patients: an analysis of two case-control studies. Am J Infect Control 34(7):447–451

      Article  PubMed  Google Scholar 

    224. Flokas ME, Karageorgos SA, Detsis M, Alevizakos M, Mylonakis E (2017) Vancomycin-resistant enterococci colonisation, risk factors and risk for infection among hospitalised paediatric patients: a systematic review and meta-analysis. Int J Antimicrob Agents 49(5):565–572

      Article  CAS  PubMed  Google Scholar 

    225. Sutcu M, Akturk H, Acar M et al (2016) Impact of vancomycin-resistant enterococci colonization in critically ill pediatric patients. Am J Infect Control 44(5):515–519

      Article  PubMed  Google Scholar 

    226. Lautenbach E, Bilker WB, Brennan PJ (1999) Enterococcal bacteremia: risk factors for vancomycin resistance and predictors of mortality. Infect Control Hosp Epidemiol 20(05):318–323

      Article  CAS  PubMed  Google Scholar 

    227. Vergis EN, Hayden MK, Chow JW et al (2001) Determinants of vancomycin resistance and mortality rates in enterococcal bacteremia. A prospective multicenter study. Ann Intern Med 135(7):484–492

      Article  CAS  PubMed  Google Scholar 

    228. Husni R, Hachem R, Hanna H, Raad I (2002) Risk factors for Vancomycin-Resistant Enterococcus (VRE) infection in colonized patients with cancer. Infect Control Hosp Epidemiol 23(2):102–103

      Article  PubMed  Google Scholar 

    229. Morris JG, Shay DK, Hebden JN et al (1995) Enterococci resistant to multiple antimicrobial agents, including vancomycin: establishment of endemicity in a university medical center. Ann Intern Med 123(4):250–259

      Article  CAS  PubMed  Google Scholar 

    230. Akturk H, Sutcu M, Somer A et al (2016) Results of four-year rectal Vancomycin-resistant Enterococci surveillance in a pediatric hematology-oncology ward: from colonization to infection. Turk J Haematol 33(3):244–247

      Article  CAS  PubMed  PubMed Central  Google Scholar 

    231. Institut für Hygiene und Umweltmedizin, Charité Berlin (2017) Outbreak Database. Worldwide Database for Nosocomial Outbreaks. https://www.outbreak-database.com . Zugegriffen: 22. März 2018

      Google Scholar 

    232. Kritsotakis EI, Christidou A, Roumbelaki M, Tselentis Y, Gikas A (2008) The dynamic relationship between antibiotic use and the incidence of vancomycin-resistant Enterococcus: time-series modelling of 7-year surveillance data in a tertiary-care hospital. Clin Microbiol Infect 14(8):747–754

      Article  CAS  PubMed  Google Scholar 

    233. Clutter DS, Dubrovskaya Y, Merl MY, Teperman L, Press R, Safdar A (2013) Fidaxomicin versus conventional antimicrobial therapy in 59 recipients of solid organ and hematopoietic stem cell transplantation with Clostridium difficile-associated diarrhea. Antimicrob Agents Chemother 57(9):4501–4505

      Article  CAS  PubMed  PubMed Central  Google Scholar 

    234. Akturk H, Sutcu M, Somer A et al (2016) Vancomycin-resistant enterococci colonization in a neonatal intensive care unit: who will be infected? J Matern Fetal Neonatal Med 29(21):3478–3482

      CAS  PubMed  PubMed Central  Google Scholar 

    235. Safdar N, Maki DG (2002) The commonality of risk factors for nosocomial colonization and infection with antimicrobial-resistant Staphylococcus aureus, enterococcus, gram-negative bacilli, Clostridium difficile, and Candida. Ann Intern Med 136(11):834–844

      Article  PubMed  Google Scholar 

    236. Papadimitriou-Olivgeris M, Drougka E, Fligou F et al (2014) Risk factors for enterococcal infection and colonization by vancomycin-resistant enterococci in critically ill patients. Infection 42(6):1013–1022

      Article  CAS  PubMed  Google Scholar 

    237. Shaked H, Carmeli Y, Schwartz D, Siegman-Igra Y (2006) Enterococcal bacteraemia: epidemiological, microbiological, clinical and prognostic characteristics, and the impact of high level gentamicin resistance. Scand J Infect Dis 38(11-12):995–1000

      Article  PubMed  Google Scholar 

    238. Watanakunakorn C, Patel R (1993) Comparison of patients with enterococcal bacteremia due to strains with and without high-level resistance to gentamicin. Clin Infect Dis 17(1):74–78

      Article  CAS  PubMed  Google Scholar 

    239. Jang HC, Lee S, Song KH et al (2010) Clinical features, risk factors and outcomes of bacteremia due to enterococci with high-level gentamicin resistance: comparison with bacteremia due to enterococci without high-level gentamicin resistance. J Korean Med Sci 25(1):3–8

      Article  PubMed  Google Scholar 

    240. McBride S, Upton A, Roberts S (2010) Clinical characteristics and outcomes of patients with vancomycin-susceptible Enterococcus faecalis and Enterococcus faecium bacteraemia—a five-year retrospective review. Eur J Clin Microbiol Infect Dis 29(1):107–114

      Article  CAS  PubMed  Google Scholar 

    241. Tripathi A, Shukla S, Singh A, Prasad K (2016) Prevalence, outcome and risk factor associated with vancomycin-resistant Enterococcus faecalis and Enterococcus faecium at a Tertiary Care Hospital in Northern India. Indian J Med Microbiol 34(1):38

      Article  CAS  PubMed  Google Scholar 

    242. Jung E, Byun S, Lee H, Moon SY, Lee H (2014) Vancomycin-resistant Enterococcus colonization in the intensive care unit: clinical outcomes and attributable costs of hospitalization. Am J Infect Control 42(10):1062–1066

      Article  PubMed  Google Scholar 

    243. Puchter L, Chaberny IF, Schwab F, Vonberg RP, Bange FC, Ebadi E (2018) Economic burden of nosocomial infections caused by vancomycin-resistant enterococci. Antimicrob Resist Infect Control 7:1

      Article  PubMed  PubMed Central  Google Scholar 

    244. Britt NS, Potter EM, Patel N, Steed ME (2015) Comparison of the effectiveness and safety of linezolid and daptomycin in vancomycin-resistant enterococcal bloodstream infection: a national cohort study of Veterans Affairs patients. Clin Infect Dis 61(6):871–878

      Article  CAS  PubMed  PubMed Central  Google Scholar 

    245. Chuang Y, Wang J, Lin H, Chang S (2014) Daptomycin versus linezolid for treatment of vancomycin-resistant enterococcal bacteremia: systematic review and meta-analysis. BMC Infect Dis 14(1):687

      Article  CAS  PubMed  PubMed Central  Google Scholar 

    246. Balli EP, Venetis CA, Miyakis S (2014) Systematic review and meta-analysis of linezolid versus daptomycin for treatment of vancomycin-resistant enterococcal bacteremia. Antimicrob Agents Chemother 58(2):734–739

      Article  CAS  PubMed  PubMed Central  Google Scholar 

    247. Ornstein MC, Mukherjee S, Keng M et al (2015) Impact of vancomycin-resistant enterococcal bacteremia on outcome during acute myeloid leukemia induction therapy. Leuk Lymphoma 56(9):2536–2542

      Article  CAS  PubMed  Google Scholar 

    248. Prematunge C, MacDougall C, Johnstone J et al (2016) VRE and VSE bacteremia outcomes in the era of effective VRE therapy: a systematic review and meta-analysis. Infect Control Hosp Epidemiol 37(01):26–35

      Article  PubMed  Google Scholar 

    249. Khair H, VanTassell P, Henderson J, Warren D, Marschall J, Program CPE (2013) Vancomycin resistance has no influence on outcomes of enterococcal bacteriuria. J Hosp Infect 85(3):183–188

      Article  CAS  PubMed  PubMed Central  Google Scholar 

    250. Pintado V, Cabellos C, Moreno S, Meseguer MA, Ayats J, Viladrich PF (2003) Enterococcal meningitis: a clinical study of 39 cases and review of the literature. Medicine (Baltimore) 82(5):346–364

      Article  Google Scholar 

    251. Forrest GN, Arnold RS, Gammie JS, Gilliam BL (2011) Single center experience of a vancomycin resistant enterococcal endocarditis cohort. J Infect 63(6):420–428

      Article  PubMed  Google Scholar 

    252. Bucheli E, Kralidis G, Boggian K et al (2014) Impact of enterococcal colonization and infection in solid organ transplantation recipients from the Swiss transplant cohort study. Transpl Infect Dis 16(1):26–36

      Article  CAS  PubMed  Google Scholar 

    253. Kim YJ, Kim SI, Choi JY, Yoon SK, You YK, Kim DG (2015) Clinical significance of methicillin-resistant Staphylococcus aureus and vancomycin-resistant enterococci colonization in liver transplant recipients. Korean J Intern Med 30(5):694–704

      Article  PubMed  PubMed Central  Google Scholar 

    254. Satlin MJ, Soave R, Racanelli AC et al (2014) The emergence of vancomycin-resistant enterococcal bacteremia in hematopoietic stem cell transplant recipients. Leuk Lymphoma 55(12):2858–2865

      Article  CAS  PubMed  PubMed Central  Google Scholar 

    255. Vydra J, Shanley RM, George I et al (2012) Enterococcal bacteremia is associated with increased risk of mortality in recipients of allogeneic hematopoietic stem cell transplantation. Clin Infect Dis 55(6):764–770

      Article  CAS  PubMed  PubMed Central  Google Scholar 

    256. Tavadze M, Rybicki L, Mossad S et al (2014) Risk factors for vancomycin-resistant enterococcus bacteremia and its influence on survival after allogeneic hematopoietic cell transplantation. Bone Marrow Transplant 49(10):1310–1316

      Article  CAS  PubMed  Google Scholar 

    257. Adams DJ, Eberly MD, Goudie A, Nylund CM (2016) Rising Vancomycin-resistant Enterococcus infections in hospitalized children in the United States. Hosp Pediatr 6(7):404–411

      Article  PubMed  Google Scholar 

    258. Chou YY, Lin TY, Lin JC, Wang NC, Peng MY, Chang FY (2008) Vancomycin-resistant enterococcal bacteremia: comparison of clinical features and outcome between Enterococcus faecium and Enterococcus faecalis. J Microbiol Immunol Infect 41(2):124–129

      PubMed  PubMed Central  Google Scholar 

    259. Hayakawa K, Marchaim D, Martin ET et al (2012) Comparison of the clinical characteristics and outcomes associated with vancomycin-resistant Enterococcus faecalis and vancomycin-resistant E. faecium bacteremia. Antimicrob Agents Chemother 56(5):2452–2458

      Article  CAS  PubMed  PubMed Central  Google Scholar 

    260. Hayakawa K, Martin ET, Gudur UM et al (2014) The impact of different antimicrobial therapies on clinical and fiscal outcomes of patients with bacteremia due to vancomycin-resistant enterococci. Antimicrob Agents Chemother 58(7):3968–3975

      Article  CAS  PubMed  PubMed Central  Google Scholar 

    261. Britt NS, Potter EM (2016) Clinical epidemiology of vancomycin-resistant Enterococcus gallinarum and Enterococcus casseliflavus bloodstream infections. J Glob Antimicrob Resist 5:57–61

      Article  PubMed  Google Scholar 

    262. Worth LJ, Thursky KA, Seymour JF, Slavin MA (2007) Vancomycin-resistant Enterococcus faecium infection in patients with hematologic malignancy: patients with acute myeloid leukemia are at high-risk. Eur J Haematol 79(3):226–233

      Article  PubMed  Google Scholar 

    263. Pogue JM, Paterson DL, Pasculle AW, Potoski BA (2007) Determination of risk factors associated with isolation of Linezolid-resistant strains of Vancomycin-resistant Enterococcus. Infect Control Hosp Epidemiol 28(12):1382–1388

      Article  PubMed  Google Scholar 

    264. Malczynski M, Qi C (2010) Differences in clinical outcomes in patients with vancomycin-resistant enterococci according to linezolid susceptibility. Pharmacotherapy 30(12):1221–1228

      Article  PubMed  Google Scholar 

    265. Santayana EM, Grim SA, Janda WM, Layden JE, Lee TA, Clark NM (2012) Risk factors and outcomes associated with vancomycin-resistant Enterococcus infections with reduced susceptibilities to linezolid. Diagn Microbiol Infect Dis 74(1):39–42

      Article  CAS  PubMed  Google Scholar 

    266. Hayakawa K, Marchaim D, Pogue JM et al (2012) Predictors and outcomes of linezolid-resistant vancomycin-resistant Enterococcus: a case-case-control study. Am J Infect Control 40(10):e261–263

      Article  PubMed  Google Scholar 

    267. Jia X, Ma W, Xu X, Yang S, Zhang L (2015) Retrospective analysis of hospital-acquired linezolid-nonsusceptible enterococci infection in Chongqing, China, 2011-2014. Am J Infect Control 43(12):e101–e106

      Article  PubMed  Google Scholar 

    268. Pai MP, Rodvold KA, Schreckenberger PC, Gonzales RD, Petrolatti JM, Quinn JP (2002) Risk factors associated with the development of infection with linezolid-and vancomycin-resistant Enterococcus faecium. Clin Infect Dis 35(10):1269–1272

      Article  PubMed  Google Scholar 

    269. Kainer MA (2007) Response to emerging infection leading to outbreak of Linezolid-resistant Enterococci. Emerging Infect Dis 13(7):1024–1030

      Article  CAS  PubMed  PubMed Central  Google Scholar 

    270. Cordina C, Hill R, Deshpande A, Hood J, Inkster T (2012) Tigecycline-resistant Enterococcus faecalis associated with omeprazole use in a surgical patient. J Antimicrob Chemother 67(7):1806–1807

      Article  CAS  PubMed  Google Scholar 

    271. Kelesidis T, Humphries R, Uslan DZ, Pegues DA (2011) Daptomycin nonsusceptible enterococci: an emerging challenge for clinicians. Clin Infect Dis 52(2):228–234

      Article  PubMed  Google Scholar 

    272. Hidron AI, Schuetz AN, Nolte FS, Gould CV, Osborn MK (2008) Daptomycin resistance in Enterococcus faecalis prosthetic valve endocarditis. J Antimicrob Chemother 61(6):1394–1396

      Article  CAS  PubMed  Google Scholar 

    273. Kanafani ZA, Federspiel JJ, Fowler VG Jr (2007) Infective endocarditis caused by daptomycin-resistant Enterococcus faecalis: a case report. Scand J Infect Dis 39(1):75–77

      Article  PubMed  Google Scholar 

    274. Green MR, Anasetti C, Sandin RL, Rolfe NE, Greene JN (2006) Development of daptomycin resistance in a bone marrow transplant patient with vancomycin-resistant Enterococcus durans. J Oncol Pharm Pract 12(3):179–181

      Article  PubMed  Google Scholar 

    275. Sabol K, Patterson JE, Lewis JS, Owens A, Cadena J, Jorgensen JH (2005) Emergence of daptomycin resistance in Enterococcus faecium during daptomycin therapy. Antimicrob Agents Chemother 49(4):1664–1665

      Article  CAS  PubMed  PubMed Central  Google Scholar 

    276. Munoz-Price LS, Lolans K, Quinn JP (2005) Emergence of resistance to daptomycin during treatment of vancomycin-resistant Enterococcus faecalis infection. Clin Infect Dis 41(4):565–566

      Article  PubMed  Google Scholar 

    277. Long JK, Choueiri TK, Hall GS, Avery RK, Sekeres MA (2005) Daptomycin-resistant Enterococcus faecium in a patient with acute myeloid leukemia. Mayo Clin Proc 80(9):1215–1216

      Article  PubMed  Google Scholar 

    278. Arias CA, Torres HA, Singh KV et al (2007) Failure of daptomycin monotherapy for endocarditis caused by an Enterococcus faecium strain with vancomycin-resistant and vancomycin-susceptible subpopulations and evidence of in vivo loss of the vanA gene cluster. Clin Infect Dis 45(10):1343–1346

      Article  CAS  PubMed  Google Scholar 

    279. Kamboj M, Cohen N, Gilhuley K, Babady NE, Seo SK, Sepkowitz KA (2011) Emergence of daptomycin-resistant VRE: experience of a single institution. Infect Control Hosp Epidemiol 32(04):391–394

      Article  PubMed  PubMed Central  Google Scholar 

    280. Kelesidis T, Humphries R, Uslan D, Pegues D (2012) De Novo Daptomycin-Nonsusceptible Enterococcal Infections. Emerging Infect Dis 18(4):674–676

      Article  PubMed  PubMed Central  Google Scholar 

    281. Wudhikarn K, Gingrich RD, de Magalhaes Silverman M (2013) Daptomycin nonsusceptible enterococci in hematologic malignancy and hematopoietic stem cell transplant patients: an emerging threat. Ann Hematol 92(1):129–131

      Article  PubMed  Google Scholar 

    282. Lewis J, Enfield K, Cox H, Mathers A, Sifri C (2016) A single-center experience with infections due to daptomycin-nonsusceptible Enterococcus faecium in liver transplant recipients. Transpl Infect Dis 18(3):341–353

      Article  CAS  PubMed  Google Scholar 

    283. Herc ES, Kauffman CA, Marini BL, Perissinotti AJ, Miceli MH (2017) Daptomycin nonsusceptible vancomycin resistant Enterococcus bloodstream infections in patients with hematological malignancies: risk factors and outcomes. Leuk Lymphoma 58(12):2852–2858

      Article  CAS  PubMed  Google Scholar 

    284. Chenoweth CE, Bradley SF, Terpenning MS et al (1994) Colonization and transmission of high-level gentamicin-resistant enterococci in a long-term care facility. Infect Control Hosp Epidemiol 15(11):703–709

      Article  CAS  PubMed  Google Scholar 

    285. Derde LPG, Cooper BS, Goossens H et al (2014) Interventions to reduce colonisation and transmission of antimicrobial-resistant bacteria in intensive care units: an interrupted time series study and cluster randomised trial. Lancet Infect Dis 14(1):31–39

      Article  PubMed  PubMed Central  Google Scholar 

    286. Fisher D, Pang L, Salmon S et al (2016) A successful vancomycin-resistant enterococci reduction bundle at a Singapore hospital. Infect Control Hosp Epidemiol 37(01):107–109

      Article  PubMed  Google Scholar 

    287. Popiel KY, Miller MA (2014) Evaluation of Vancomycin-Resistant Enterococci (VRE)–Associated Morbidity Following Relaxation of VRE Screening and Isolation Precautions in a Tertiary Care Hospital. Infect Control Hosp Epidemiol 35(07):818–825

      Article  PubMed  Google Scholar 

    288. Montecalvo MA, Jarvis WR, Uman J et al (1999) Infection-control measures reduce transmission of vancomycin-resistant enterococci in an endemic setting. Ann Intern Med 131(4):269–272

      Article  CAS  PubMed  Google Scholar 

    289. Price CS, Paule S, Noskin GA, Peterson LR (2003) Active surveillance reduces the incidence of vancomycin-resistant enterococcal bacteremia. Clin Infect Dis 37(7):921–928

      Article  PubMed  Google Scholar 

    290. Ostrowsky BE, Trick WE, Sohn AH et al (2001) Control of vancomycin-resistant enterococcus in health care facilities in a region. N Engl J Med 344(19):1427–1433

      Article  CAS  PubMed  Google Scholar 

    291. Garbutt JM, Littenberg B, Evanoff BA, Sahm D, Mundy LM (1999) Enteric carriage of vancomycin-resistant Enterococcus faecium in patients tested for Clostridium difficile. Infect Control Hosp Epidemiol 20(10):664–670

      Article  CAS  PubMed  Google Scholar 

    292. Özsoy S, Ilki A (2017) Detection of vancomycin-resistant enterococci (VRE) in stool specimens submitted for Clostridium difficile toxin testing. Braz J Microbiol 48(3):489–492

      Article  PubMed  PubMed Central  Google Scholar 

    293. Leber AL, Hindler JF, Kato EO, Bruckner DA, Pegues DA (2001) Laboratory-based surveillance for vancomycin-resistant enterococci: utility of screening stool specimens submitted for Clostridium difficile toxin assay. Infect Control Hosp Epidemiol 22(3):160–164

      Article  CAS  PubMed  Google Scholar 

    294. Bodily M, McMullen KM, Russo AJ, Kittur ND, Hoppe-Bauer J, Warren DK (2013) Discontinuation of reflex testing of stool samples for vancomycin-resistant enterococci resulted in increased prevalence. Infect Control Hosp Epidemiol 34(8):838–840

      Article  PubMed  PubMed Central  Google Scholar 

    295. Munigala S, McMullen KM, Russo AJ et al (2017) Reinstatement of reflex testing of stool samples for Vancomycin-Resistant Enterococci (VRE) resulted in decreased incidence of hospital-associated VRE. Infect Control Hosp Epidemiol 38(5):619–621

      Article  PubMed  PubMed Central  Google Scholar 

    296. Cetinkaya Y, Falk P, Mayhall CG (2000) Vancomycin-resistant enterococci. Clin Microbiol Rev 13(4):686–707

      Article  CAS  PubMed  PubMed Central  Google Scholar 

    297. D´Agata EMD, Gautam S, Green WK, Tang Y-W (2002) High rate of false-negative results of the rectal swab culture method in detection of gastrointestinal colonization with vancomycin-resistant enterococci. Clin Infect Dis 34(2):167–172

      Article  Google Scholar 

    298. Warnke P, Warning L, Podbielski A (2014) Some are more equal - A comparative study on swab uptake and release of bacterial suspensions. PLoS ONE 9(7):e102215

      Article  CAS  PubMed  PubMed Central  Google Scholar 

    299. Pearman JW (2006) 2004 Lowbury Lecture: the Western Australian experience with vancomycin-resistant enterococci - from disaster to ongoing control. J Hosp Infect 63(1):14–26

      Article  CAS  PubMed  Google Scholar 

    300. Drews SJ, Johnson G, Gharabaghi F et al (2006) A 24-hour screening protocol for identification of vancomycin-resistant Enterococcus faecium. J Clin Microbiol 44(4):1578–1580

      Article  CAS  PubMed  PubMed Central  Google Scholar 

    301. Wade JJ (1995) The emergence of Enterococcus faecium resistant to glycopeptides and other standard agents - a preliminary report. J Hosp Infect 30:483–493

      Article  PubMed  Google Scholar 

    302. Novicki TJ, Schapiro JM, Ulness BK et al (2004) Convenient selective differential broth for isolation of vancomycin-resistant Enterococcus from fecal material. J Clin Microbiol 42(4):1637–1640

      Article  PubMed  PubMed Central  Google Scholar 

    303. Stamper PD, Shulder S, Bekalo P et al (2010) Evaluation of BBL CHROMagar VanRE for detection of vancomycin-resistant Enterococci in rectal swab specimens. J Clin Microbiol 48(11):4294–4297

      Article  PubMed  PubMed Central  Google Scholar 

    304. Malhotra-Kumar S, Haccuria K, Michiels M et al (2008) Current trends in rapid diagnostics for methicillin-resistant Staphylococcus aureus and glycopeptide-resistant enterococcus species. J Clin Microbiol 46(5):1577–1587

      Article  PubMed  PubMed Central  Google Scholar 

    305. Suwantarat N, Roberts A, Prestridge J et al (2014) Comparison of five chromogenic media for recovery of vancomycin-resistant enterococci from fecal samples. J Clin Microbiol 52(11):4039–4042

      Article  PubMed  PubMed Central  Google Scholar 

    306. Brown DF, Walpole E (2003) Evaluation of selective and enrichment media for isolation of glycopeptide-resistant enterococci from faecal specimens. J Antimicrob Chemother 51(2):289–296

      Article  CAS  PubMed  Google Scholar 

    307. Werner G, Serr A, Schütt S et al (2011) Comparison of direct cultivation on a selective solid medium, polymerase chain reaction from an enrichment broth, and the BD GeneOhm™ VanR Assay for identification of vancomycin-resistant enterococci in screening specimens. Diagn Microbiol Infect Dis 70(4):512–521

      Article  CAS  PubMed  Google Scholar 

    308. Papadimitriou-Olivgeris M, Filippidou S, Kolonitsiou F et al (2016) Pitfalls in the identification of Enterococcus species and the detection of vanA and vanB genes. Lett Appl Microbiol 63(3):189–195

      Article  CAS  PubMed  Google Scholar 

    309. Babady NE, Gilhuley K, Cianciminio-Bordelon D, Tang YW (2012) Performance characteristics of the Cepheid Xpert vanA assay for rapid identification of patients at high risk for carriage of vancomycin-resistant Enterococci. J Clin Microbiol 50(11):3659–3663

      Article  PubMed  PubMed Central  Google Scholar 

    310. Franke GC, Klupp EM, Mirwald N et al (2015) Real life evaluation of VRE vanA/vanB real-time PCR for surveillance of vancomycin-resistant enterococci in rectal swab samples. P0767. Poster session presented at the meeting of the ESCMID, Copenhagen. ,

    311. Lucet JC, Armand-Lefevre L, Laurichesse JJ et al (2007) Rapid control of an outbreak of vancomycin-resistant enterococci in a French university hospital. J Hosp Infect 67(1):42–48

      Article  PubMed  Google Scholar 

    312. Wang JT, Chen YC, Chang SC et al (2004) Control of vancomycin-resistant enterococci in a hospital: a five-year experience in a Taiwanese teaching hospital. J Hosp Infect 58(2):97–103

      Article  PubMed  Google Scholar 

    313. Bearman GM, Marra AR, Sessler CN et al (2007) A controlled trial of universal gloving versus contact precautions for preventing the transmission of multidrug-resistant organisms. Am J Infect Control 35(10):650–655

      Article  PubMed  Google Scholar 

    314. Bearman G, Rosato AE, Duane TM et al (2010) Trial of universal gloving with emollient-impregnated gloves to promote skin health and prevent the transmission of multidrug-resistant organisms in a surgical intensive care unit. Infect Control Hosp Epidemiol 31(5):491–497

      Article  PubMed  Google Scholar 

    315. Harris AD, Pineles L, Belton B et al (2013) Universal glove and gown use and acquisition of antibiotic-resistant bacteria in the ICU: a randomized trial. JAMA 310(15):1571–1580

      CAS  PubMed  PubMed Central  Google Scholar 

    316. Aboelela SW, Saiman L, Stone P, Lowy FD, Quiros D, Larson E (2006) Effectiveness of barrier precautions and surveillance cultures to control transmission of multidrug-resistant organisms: a systematic review of the literature. Am J Infect Control 34(8):484–494

      Article  PubMed  Google Scholar 

    317. Cohen C, Cohen B, Shang J (2015) Effectiveness of contact precautions against multidrug-resistant organism transmission in acute care: a systematic review of the literature. J Hosp Infect 90(4):275–284

      Article  CAS  PubMed  PubMed Central  Google Scholar 

    318. De Angelis G, Cataldo MA, De Waure C et al (2014) Infection control and prevention measures to reduce the spread of vancomycin-resistant enterococci in hospitalized patients: a systematic review and meta-analysis. J Antimicrob Chemother 69(5):1185–1192

      Article  CAS  PubMed  Google Scholar 

    319. Edmond MB, Masroor N, Stevens MP, Ober J, Bearman G (2015) The impact of discontinuing contact precautions for VRE and MRSA on device-associated infections. Infect Control Hosp Epidemiol 36(8):978–980

      Article  PubMed  Google Scholar 

    320. Almyroudis NG, Osawa R, Samonis G et al (2016) Discontinuation of systematic surveillance and contact precautions for Vancomycin-Resistant Enterococcus (VRE) and its impact on the incidence of VRE faecium Bacteremia in patients with hematologic malignancies. Infect Control Hosp Epidemiol 37(4):398–403

      Article  PubMed  Google Scholar 

    321. Bardossy AC, Alsafadi MY, Starr P et al (2017) Evaluation of contact precautions for methicillin-resistant Staphylococcus aureus and vancomycin-resistant Enterococcus. Am J Infect Control 45(12):1369–1371

      Article  PubMed  Google Scholar 

    322. Marra AR, Edmond MB, Schweizer ML, Ryan GW, Diekema DJ (2018) Discontinuing contact precautions for multidrug-resistant organisms: a systematic literature review and meta-analysis. Am J Infect Control 46(3):333–340

      Article  PubMed  Google Scholar 

    323. Armeanu E, Bonten MJ (2005) Control of vancomycin-resistant enterococci: one size fits all? Clin Infect Dis 41(2):210–216

      Article  PubMed  Google Scholar 

    324. Venkatesh AK, Lankford MG, Rooney DM, Blachford T, Watts CM, Noskin GA (2008) Use of electronic alerts to enhance hand hygiene compliance and decrease transmission of vancomycin-resistant Enterococcus in a hematology unit. Am J Infect Control 36(3):199–205

      Article  PubMed  Google Scholar 

    325. Jayaraman SP, Klompas M, Bascom M et al (2014) Hand-hygiene compliance does not predict rates of resistant infections in critically ill surgical patients. Surg Infect (Larchmt) 15(5):533–539

      Article  Google Scholar 

    326. Tenorio AR, Badri SM, Sahgal NB et al (2001) Effectiveness of gloves in the prevention of hand carriage of vancomycin-resistant enterococcus species by health care workers after patient care. Clin Infect Dis 32(5):826–829

      Article  CAS  PubMed  Google Scholar 

    327. Puzniak LA, Leet T, Mayfield J, Kollef M, Mundy LM (2002) To gown or not to gown: the effect on acquisition of vancomycin-resistant enterococci. Clin Infect Dis 35(1):18–25

      Article  PubMed  Google Scholar 

    328. Srinivasan A, Song X, Ross T, Merz W, Brower R, Perl TM (2002) A prospective study to determine whether cover gowns in addition to gloves decrease nosocomial transmission of vancomycin-resistant enterococci in an intensive care unit. Infect Control Hosp Epidemiol 23(8):424–428

      Article  PubMed  Google Scholar 

    329. Perugini MR, Nomi SM, Lopes GK et al (2011) Impact of the reduction of environmental and equipment contamination on vancomycin-resistant enterococcus rates. Infection 39(6):587–593

      Article  CAS  PubMed  Google Scholar 

    330. Cheng VC, Tai JW, Chau P et al (2016) Successful control of emerging vancomycin-resistant enterococci by territory-wide implementation of directly observed hand hygiene in patients in Hong Kong. Am J Infect Control 44(10):1168–1171

      Article  PubMed  Google Scholar 

    331. Bradley SJ, Wilson AL, Allen MC, Sher HA, Goldstone AH, Scott GM (1999) The control of hyperendemic glycopeptide-resistant Enterococcus spp. on a haematology unit by changing antibiotic usage. J Antimicrob Chemother 43(2):261–266

      Article  CAS  PubMed  Google Scholar 

    332. Cohen B, Cohen CC, Loyland B, Larson EL (2017) Transmission of health care-associated infections from roommates and prior room occupants: a systematic review. Clin Epidemiol 9:297–310

      Article  PubMed  PubMed Central  Google Scholar 

    333. Knelson LP, Williams DA, Gergen MF et al (2014) A comparison of environmental contamination by patients infected or colonized with methicillin-resistant Staphylococcus aureus or vancomycin-resistant enterococci: a multicenter study. Infect Control Hosp Epidemiol 35(7):872–875

      Article  PubMed  PubMed Central  Google Scholar 

    334. Ford CD, Lopansri BK, Gazdik MA et al (2016) Room contamination, patient colonization pressure, and the risk of vancomycin-resistant Enterococcus colonization on a unit dedicated to the treatment of hematologic malignancies and hematopoietic stem cell transplantation. Am J Infect Control 44(10):1110–1115

      Article  PubMed  Google Scholar 

    335. Falagas M, Thomaidis P, Kotsantis I, Sgouros K, Samonis G, Karageorgopoulos D (2011) Airborne hydrogen peroxide for disinfection of the hospital environment and infection control: a systematic review. J Hosp Infect 78(3):171–177

      Article  CAS  PubMed  Google Scholar 

    336. Passaretti CL, Otter JA, Reich NG et al (2013) An evaluation of environmental decontamination with hydrogen peroxide vapor for reducing the risk of patient acquisition of multidrug-resistant organisms. Clin Infect Dis 56(1):27–35

      Article  CAS  PubMed  Google Scholar 

    337. Horn K, Otter JA (2015) Hydrogen peroxide vapor room disinfection and hand hygiene improvements reduce Clostridium difficile infection, methicillin-resistant Staphylococcus aureus, vancomycin-resistant enterococci, and extended-spectrum beta-lactamase. Am J Infect Control 43(12):1354–1356

      Article  PubMed  Google Scholar 

    338. Reichenbacher D, Thanheiser M, Krüger D (2010) Aktueller Stand zur Raumdekontamination mit gasförmigem Wasserstoffperoxid Status quo of room decontamination by vaporized hydrogen peroxide. Hyg Med 35(6):204–208

      Google Scholar 

    339. Robert Koch-Institut (RKI) (2017) 3.3. Raumdesinfektion. In: Robert Koch-Institut (RKI) Liste der vom Robert Koch-Institut geprüften und anerkannten Desinfektionsmittel und -verfahren (17. Ausgabe). Bundesgesundheitsblatt 60(11):1274–1297

      Article  Google Scholar 

    340. Byrns G, Fuller TP (2011) The risks and benefits of chemical fumigation in the health care environment. J Occup Environ Hyg 8(2):104–112

      Article  PubMed  Google Scholar 

    341. Popp W (2014) Probleme bei der Etablierung eines Wasserstoffperoxid-Verneblers. Hyg Med 39(3):77–80

      Google Scholar 

    342. Grabsch EA, Mahony AA, Cameron DR et al (2012) Significant reduction in vancomycin-resistant enterococcus colonization and bacteraemia after introduction of a bleach-based cleaning-disinfection programme. J Hosp Infect 82(4):234–242

      Article  CAS  PubMed  Google Scholar 

    343. Bryce E, Grant J, Scharf S et al (2015) Horizontal infection prevention measures and a risk-managed approach to vancomycin-resistant enterococci: an evaluation. Am J Infect Control 43(11):1238–1243

      Article  PubMed  Google Scholar 

    344. Brooks S, Khan A, Stoica D et al (1998) Reduction in vancomycin-resistant Enterococcus and Clostridium difficile infections following change to tympanic thermometers. Infect Control Hosp Epidemiol 19(5):333–336

      Article  CAS  PubMed  Google Scholar 

    345. Climo MW, Sepkowitz KA, Zuccotti G et al (2009) The effect of daily bathing with chlorhexidine on the acquisition of methicillin-resistant Staphylococcus aureus, vancomycin-resistant Enterococcus, and healthcare-associated bloodstream infections: results of a quasi-experimental multicenter trial. Crit Care Med 37(6):1858–1865

      Article  CAS  PubMed  Google Scholar 

    346. Kassakian SZ, Mermel LA, Jefferson JA, Parenteau SL, Machan JT (2011) Impact of Chlorhexidine bathing on hospital-acquired infections among general medical patients. Infect Control Hosp Epidemiol 32(3):238–243

      Article  PubMed  Google Scholar 

    347. Gastmeier P, Kämpf K-P, Behnke M, Geffers C, Schwab F (2016) An observational study of the universal use of octenidine to decrease nosocomial bloodstream infections and MDR organisms. J Antimicrob Chemother 71(9):2569–2576

      Article  CAS  PubMed  Google Scholar 

    348. Chen WS, Li SQ, Li LH, Wu X, Zhang WH (2013) Effects of daily bathing with chlorhexidine and acquired infection of methicillin-resistant Staphylococcus aureus and vancomycin-resistant Enterococcus: a meta-analysis. J Thorac Dis 5(4):518–524

      PubMed  PubMed Central  Google Scholar 

    349. Dicks KV, Lofgren E, Lewis SS, Moehring RW, Sexton DJ, Anderson DJ (2016) A multicenter pragmatic interrupted time series analysis of Chlorhexidine Gluconate bathing in community hospital intensive care units. Infect Control Hosp Epidemiol 37(7):791–797

      Article  PubMed  PubMed Central  Google Scholar 

    350. Martin EM, Russell D, Rubin Z et al (2016) Elimination of routine contact precautions for endemic Methicillin-resistant staphylococcus aureus and Vancomycin-Resistant Enterococcus: a retrospective quasi-experimental study. Infect Control Hosp Epidemiol 37(11):1323–1330

      Article  PubMed  Google Scholar 

    351. Guzman Prieto AM, Wijngaarden J, Braat JC et al (2017) The two-component system ChtRS contributes to Chlorhexidine tolerance in Enterococcus faecium. Antimicrob Agents Chemother 61(5):e02122-16

      Article  PubMed  PubMed Central  Google Scholar 

    352. O'Donovan CA, Fan-Havard P, Tecson-Tumang FT, Smith SM, Eng RH (1994) Enteric eradication of vancomycin-resistant Enterococcus faecium with oral bacitracin. Diagn Microbiol Infect Dis 18(2):105–109

      Article  CAS  PubMed  Google Scholar 

    353. Weinstein MR, Dedier H, Brunton J, Campbell I, Conly JM (1999) Lack of efficacy of oral bacitracin plus doxycycline for the eradication of stool colonization with vancomycin-resistant Enterococcus faecium. Clin Infect Dis 29(2):361–366

      Article  CAS  PubMed  Google Scholar 

    354. Brossier F, Lefrancois S, Paute J et al (2010) Decolonisation for early control of an outbreak of vancomycin-resistant Enterococcus faecium in a geriatric rehabilitation care facility. J Hosp Infect 76(4):368–369

      Article  CAS  PubMed  Google Scholar 

    355. Chia JK, Nakata MM, Park SS, Lewis RP, McKee B (1995) Use of bacitracin therapy for infection due to vancomycin-resistant Enterococcus faecium. Clin Infect Dis 21(6):1520

      Article  CAS  PubMed  Google Scholar 

    356. Mondy KE, Shannon W, Mundy LM (2001) Evaluation of zinc bacitracin capsules versus placebo for enteric eradication of vancomycin-resistant Enterococcus faecium. Clin Infect Dis 33(4):473–476

      Article  CAS  PubMed  Google Scholar 

    357. Hachem R, Raad I (2002) Failure of oral antimicrobial agents in eradicating gastrointestinal colonization with vancomycin-resistant enterococci. Infect Control Hosp Epidemiol 23(1):43–44

      Article  PubMed  Google Scholar 

    358. Wong MT, Kauffman CA, Standiford HC et al (2001) Effective suppression of vancomycin-resistant Enterococcus species in asymptomatic gastrointestinal carriers by a novel glycolipodepsipeptide, ramoplanin. Clin Infect Dis 33(9):1476–1482

      Article  CAS  PubMed  Google Scholar 

    359. Montecalvo MA (2003) Ramoplanin: a novel antimicrobial agent with the potential to prevent vancomycin-resistant enterococcal infection in high-risk patients. J Antimicrob Chemother 51(Suppl 3):iii31–iii35

      CAS  PubMed  PubMed Central  Google Scholar 

    360. Montecalvo MA, Horowitz H, Wormser GP, Seiter K, Carbonaro CA (1995) Effect of novobiocin-containing antimicrobial regimens on infection and colonization with vancomycin-resistant Enterococcus faecium. Antimicrob Agents Chemother 39(3):794

      Article  CAS  PubMed  PubMed Central  Google Scholar 

    361. Heineman J, Bubenik S, McClave S, Martindale R (2012) Fighting fire with fire: is it time to use probiotics to manage pathogenic bacterial diseases? Curr Gastroenterol Rep 14(4):343–348

      Article  PubMed  Google Scholar 

    362. Manley KJ, Fraenkel MB, Mayall BC, Power DA (2007) Probiotic treatment of vancomycin-resistant enterococci: a randomised controlled trial. Med J Aust 186(9):454–457

      PubMed  PubMed Central  Google Scholar 

    363. Szachta P, Ignys I, Cichy W (2011) An evaluation of the ability of the probiotic strain Lactobacillus rhamnosus GG to eliminate the gastrointestinal carrier state of vancomycin-resistant enterococci in colonized children. J Clin Gastroenterol 45(10):872–877

      Article  PubMed  Google Scholar 

    364. de Regt MJ, Willems RJ, Hene RJ et al (2010) Effects of probiotics on acquisition and spread of multiresistant enterococci. Antimicrob Agents Chemother 54(7):2801–2805

      Article  CAS  PubMed  PubMed Central  Google Scholar 

    365. Warrack S, Ziegler M, Duster M, Panjikar P, Safdar N (2016) A pilot randomized trial to determine the tolerability of a Probiotic in patients colonized with Vancomycin-resistant Enterococcus. J Prob Health 4(2):142

      Google Scholar 

    366. Doron S, Snydman DR (2015) Risk and safety of probiotics. Clin Infect Dis 60(Suppl 2):S129–S134

      Article  PubMed  PubMed Central  Google Scholar 

    367. Haghighat L, Crum-Cianflone NF (2016) The potential risks of probiotics among HIV-infected persons: Bacteraemia due to lactobacillus acidophilus and review of the literature. Int J Std Aids 27(13):1223–1230

      Article  PubMed  Google Scholar 

    368. Zbinden A, Zbinden R, Berger C, Arlettaz R (2015) Case series of Bifidobacterium longum bacteremia in three preterm infants on probiotic therapy. Neonatology 107(1):56–59

      Article  PubMed  Google Scholar 

    369. Lund B, Edlund C (2001) Probiotic Enterococcus faecium strain is a possible recipient of the vanA gene cluster. Clin Infect Dis 32(9):1384–1385

      Article  CAS  PubMed  Google Scholar 

    370. Ubeda C, Bucci V, Caballero S et al (2013) Intestinal microbiota containing Barnesiella species cures vancomycin-resistant Enterococcus faecium colonization. Infect Immun 81(3):965–973

      Article  CAS  PubMed  PubMed Central  Google Scholar 

    371. Davido B, Batista R, Fessi H, Salomon J, Dinh A (2017) Impact of faecal microbiota transplantation to eradicate vancomycin-resistant enterococci (VRE) colonization in humans. J Infect 75(4):376–377

      Article  PubMed  Google Scholar 

    372. Sohn KM, Cheon S, Kim YS (2016) Can Fecal Microbiota Transplantation (FMT) Eradicate Fecal Colonization With Vancomycin-Resistant Enterococci (VRE)? Infect Control Hosp Epidemiol 37(12):1519–1521

      Article  PubMed  Google Scholar 

    373. Tacconelli E, De Angelis G, Cataldo MA et al (2009) Antibiotic usage and risk of colonization and infection with antibiotic-resistant bacteria: a hospital population-based study. Antimicrob Agents Chemother 53(10):4264–4269

      Article  CAS  PubMed  PubMed Central  Google Scholar 

    374. McKinnell JA, Kunz DF, Chamot E et al (2012) Association between vancomycin-resistant Enterococci bacteremia and ceftriaxone usage. Infect Control Hosp Epidemiol 33(7):718–724

      Article  PubMed  Google Scholar 

    375. Gouliouris T, Warne B, Cartwright EJP et al (2018) Duration of exposure to multiple antibiotics is associated with increased risk of VRE bacteraemia: a nested case-control study. J Antimicrob Chemother 73(6):1692–1699

      Article  PubMed  PubMed Central  Google Scholar 

    376. Mauldin PD, Salgado CD, Durkalski VL, Bosso JA (2008) Nosocomial infections due to methicillin-resistant Staphylococcus aureus and vancomycin-resistant enterococcus: relationships with antibiotic use and cost drivers. Ann Pharmacother 42(3):317–326

      Article  PubMed  Google Scholar 

    377. McKinnell JA, Kunz DF, Moser SA et al (2016) Patient-level analysis of incident vancomycin-resistant enterococci colonization and antibiotic days of therapy. Epidemiol Infect 144(8):1748–1755

      Article  CAS  PubMed  PubMed Central  Google Scholar 

    378. Hospital Infection Control Practices Advisory Committee (HICPAC) (1995) Recommendations for preventing the spread of vancomycin resistance. MMWR Recomm Rep 44(RR-12):1–13

      Google Scholar 

    379. Belliveau PP, Rothman AL, Maday CE (1996) Limiting vancomycin use to combat vancomycin-resistant Enterococcus faecium. Am J Health Syst Pharm 53(13):1570–1575

      CAS  PubMed  PubMed Central  Google Scholar 

    380. Shaikh ZH, Osting CA, Hanna HA, Arbuckle RB, Tarr JJ, Raad II (2002) Effectiveness of a multifaceted infection control policy in reducing vancomycin usage and vancomycin-resistant enterococci at a tertiary care cancer centre. J Hosp Infect 51(1):52–58

      Article  CAS  PubMed  Google Scholar 

    381. Anglim AM, Klym B, Byers KE, Scheld WM, Farr BM (1997) Effect of a vancomycin restriction policy on ordering practices during an outbreak of vancomycin-resistant Enterococcus faecium. Arch Intern Med 157(10):1132–1136

      Article  CAS  PubMed  Google Scholar 

    382. Meyer E, Schwab F, Schroeren-Boersch B, Gastmeier P (2010) Dramatic increase of third-generation cephalosporin-resistant E. coli in German intensive care units: secular trends in antibiotic drug use and bacterial resistance, 2001 to 2008. Crit Care 14(3):R113

      Article  PubMed  PubMed Central  Google Scholar 

    383. Smith RL, Evans HL, Chong TW et al (2008) Reduction in rates of methicillin-resistant Staphylococcus aureus infection after introduction of quarterly linezolid-vancomycin cycling in a surgical intensive care unit. Surg Infect (Larchmt) 9(4):423–431

      Article  Google Scholar 

    384. May AK, Melton SM, McGwin G, Cross JM, Moser SA, Rue LW (2000) Reduction of vancomycin-resistant enterococcal infections by limitation of broad-spectrum cephalosporin use in a trauma and burn intensive care unit. Shock 14(3):259–264

      Article  CAS  PubMed  Google Scholar 

    385. Lautenbach E, LaRosa LA, Marr AM, Nachamkin I, Bilker WB, Fishman NO (2003) Changes in the prevalence of vancomycin-resistant enterococci in response to antimicrobial formulary interventions: impact of progressive restrictions on use of vancomycin and third-generation cephalosporins. Clin Infect Dis 36(4):440–446

      Article  CAS  PubMed  Google Scholar 

    386. Arda B, Sipahi OR, Yamazhan T et al (2007) Short-term effect of antibiotic control policy on the usage patterns and cost of antimicrobials, mortality, nosocomial infection rates and antibacterial resistance. J Infect 55(1):41–48

      Article  PubMed  Google Scholar 

    387. Peto Z, Benko R, Matuz M, Csullog E, Molnar A, Hajdu E (2008) Results of a local antibiotic management program on antibiotic use in a tertiary intensive care unit in Hungary. Infection 36(6):560–564

      Article  CAS  PubMed  Google Scholar 

    388. Jaggi N, Sissodia P, Sharma L (2012) Control of multidrug resistant bacteria in a tertiary care hospital in India. Antimicrob Resist Infect Control 1(1):23

      Article  PubMed  PubMed Central  Google Scholar 

    389. de Bruin MA, Riley LW (2007) Does vancomycin prescribing intervention affect vancomycin-resistant enterococcus infection and colonization in hospitals? A systematic review. BMC Infect Dis 7:24

      Article  CAS  PubMed  PubMed Central  Google Scholar 

    390. Tacconelli E (2009) Antimicrobial use: risk driver of multidrug resistant microorganisms in healthcare settings. Curr Opin Infect Dis 22(4):352–358

      Article  CAS  PubMed  Google Scholar 

    391. Baur D, Gladstone BP, Burkert F et al (2017) Effect of antibiotic stewardship on the incidence of infection and colonisation with antibiotic-resistant bacteria and Clostridium difficile infection: a systematic review and meta-analysis. Lancet Infect Dis 17(9):990–1001

      Article  PubMed  Google Scholar 

    392. Climo MW, Yokoe DS, Warren DK et al (2013) Effect of daily Chlorhexidine bathing on hospital-acquired infection. N Engl J Med 368(6):533–542

      Article  CAS  PubMed  PubMed Central  Google Scholar 

    393. Musuuza JS, Sethi AK, Roberts TJ, Safdar N (2017) Implementation of daily chlorhexidine bathing to reduce colonization by multidrug-resistant organisms in a critical care unit. Am J Infect Control 45(9):1014–1017

      Article  CAS  PubMed  Google Scholar 

    394. Frakking FNJ, Bril WS, Sinnige JC et al (2018) Recommendations for the successful control of a large outbreak of vancomycin-resistant Enterococcus faecium in a non-endemic hospital setting. J Hosp Infect. https://doi.org/10.1016/j.jhin.2018.02.016

      Article  PubMed  PubMed Central  Google Scholar 

    395. Slaughter S, Hayden MK, Nathan C et al (1996) A comparison of the effect of universal use of gloves and gowns with that of glove use alone on acquisition of vancomycin-resistant enterococci in a medical intensive care unit. Ann Intern Med 125(6):448–456

      Article  CAS  PubMed  Google Scholar 

    396. Gandra S, Barysauskas C, Mack DA, Barton B, Finberg R, Ellison RT III (2014) Impact of contact precautions on falls, pressure ulcers and transmission of MRSA and VRE in hospitalized patients. J Hosp Infect 88(3):170–176

      Article  CAS  PubMed  Google Scholar 

    397. Rupp ME, Fitzgerald T, Hayes K et al (2017) Effect of cessation of contact isolation for endemic methicillin-resistant staphylococcus aureus and vancomycin-resistant enterococci. Infect Control Hosp Epidemiol 38(8):1005–1007

      Article  PubMed  Google Scholar 

    398. Lemieux C, Gardam M, Evans G et al (2017) Longitudinal multicenter analysis of outcomes after cessation of control measures for vancomycin-resistant enterococci. Infect Control Hosp Epidemiol 38(1):24–30

      Article  PubMed  Google Scholar 

    399. Muto CA, Jernigan JA, Ostrowsky BE et al (2003) SHEA guideline for preventing nosocomial transmission of multidrug-resistant strains of Staphylococcus aureus and enterococcus. Infect Control Hosp Epidemiol 24(5):362–386

      Article  PubMed  Google Scholar 

    400. Siegel JD, Rhinehart E, Jackson M, Chiarello L (2007) Management of multidrug-resistant organisms in health care settings, 2006. Am J Infect Control 35(10 Suppl 2):S165–S193

      Article  PubMed  Google Scholar 

    401. Government of South Australia (SA Health) (2017) Management of Patients with Vancomycin-resistant Enterococci (VRE) Clinical Guideline. Version 6.2. http://www.sahealth.sa.gov.au/wps/wcm/connect/public+content/sa+health+internet/resources/policies/vancomycin-resistant+enterococci+vre+patient+management+clinical+guideline . Zugegriffen: 22. März 2018

      Google Scholar 

    402. Lepelletier D, Berthelot P, Lucet JC, Fournier S, Jarlier V, Grandbastien B (2015) French recommendations for the prevention of 'emerging extensively drug-resistant bacteria' (eXDR) cross-transmission. J Hosp Infect 90(3):186–195

      Article  CAS  PubMed  Google Scholar 

    403. Kluytmans-VandenBergh MFQ, Kluytmans JAJW, Voss A (2005) Dutch guideline for preventing nosocomial transmission of highly resistant microorganisms (HRMO). Infection 33(5-6):309–313

      Article  CAS  PubMed  Google Scholar 

    404. Cookson BD, Macrae MB, Barrett SP et al (2006) Guidelines for the control of glycopeptide-resistant enterococci in hospitals. J Hosp Infect 62(1):6–21

      Article  CAS  PubMed  Google Scholar 

    Download references

    Rights and permissions

    Reprints and Permissions

    About this article

    Verify currency and authenticity via CrossMark

    Cite this article

    Hygienemaßnahmen zur Prävention der Infektion durch Enterokokken mit speziellen Antibiotikaresistenzen. Bundesgesundheitsbl 61, 1310–1361 (2018). https://doi.org/10.1007/s00103-018-2811-2

    Download citation

    • Published:

    • Issue Date:

    • DOI: https://doi.org/10.1007/s00103-018-2811-2